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ABSTRACT OF THE DISSERTATION
Structure and Dynamics of a Small Multidrug Resistance Transporter, EmrE
by
Chao Wu
Doctor of Philosophy in Biology and Biomedical Sciences
Computational and Molecular Biophysics
Washington University in St. Louis, 2016
Professor Katherine A. Henzler-Wildman, Chair

EmrE is a small multidrug resistance transporter in E. coli. It effluxes a wide range of antibiotics,
thus contributing to the evolving epidemic of drug resistance. Despite its small size, EmrE is a
fully functional transporter making it an ideal model system for a comprehensive study of the
multidrug transport mechanism. In the transport cycle, EmrE must alternate between outwardand inward-facing conformations upon substrate binding to translocate substrates across the
membrane. High-resolution structures of EmrE in complex with substrates facing different sides
of the membrane will shed light on the coupling mechanism between substrate binding and
transport. However, the conformational plasticity that enables EmrE to transport diverse drugs
also makes it a very challenging system for high-resolution structural studies. The
conformational dynamics inherent in the transport process require experimental measures of
structural transitions to provide the link between static structures and functional transport. This
thesis aims to characterize the structure and dynamics of EmrE in atomic detail using NMR, a
well-established technique to study structure and dynamics of biomolecules simultaneously
under a variety of conditions.

xi

In the case of EmrE, NMR spectroscopy is the best approach for high-resolution structures
because the dynamic nature and small size of EmrE hamper X-ray crystallography and cryoEM
approaches. I have made significant progress towards a better structure of EmrE using a slowdynamics mutant and have achieved a near complete backbone and side chain ILV methyl
assignment for this highly challenging helical membrane protein system. I have also collected a
large data set of distance and orientational restraints. I have also used NMR and functional
assays to characterize a series of mutants located near the transmembrane helix 3 (TM3) kink
and have demonstrated the important role of TM3 kink formation for the global conformational
interconversion required for alternating-access. My NMR data also suggest that hydration within
the transport pore may be an important property fine-tuning the rates of conformational
interconversion. My NMR pH titrations show that the slow-dynamics mutant also has elevated
pKa values for E14, the critical residue for proton-coupling in EmrE. This provides the first
experimental evidence of the physicochemical link between proton and substrate binding and
alternating-access necessary for achieving coupled transport. By correlating high-resolution
structural and dynamic data with functional transport assays, this thesis provides key insights
into the multidrug transport mechanism of EmrE. The principles learned for EmrE set the stage
for understanding even more challenging transporters.

xii

Chapter 1: Introduction
“If we were to name the most powerful assumption of all, which leads one on and on in an
attempt to understand life, it is that all things are made of atoms, and that everything that living
things do can be understood in terms of jigglings and wigglings of atoms.”
--- Richard Feynman, The Feynman Lectures on Physics
One of the emerging principles in biochemistry and molecular biology is that the functions of
biological molecules is ultimately rooted in the physical motions of atoms composing these
molecules1. Understanding the nature of these motions at different time and length scales is
deeply linked to comprehending molecular mechanisms. With the great success of structural
biology in the past decades, we now have the luxury of researching biology at the atomic level.
To move beyond structure-function relationships and construct the new paradigm: structuredynamics-function, both spatial and temporal resolutions are essential. Despite recent exciting
progress in biophysical techniques, e.g. spectroscopy and modeling, the field of biomolecular
dynamics remains immature due to the limitations of current theories, the tremendous technical
difficulties, and the challenging interpretations of dynamic information from measured physical
properties.
In my doctoral thesis, I focus on a small multidrug resistance transporter, EmrE, to study its
structure and dynamics by using NMR spectroscopy and other biophysical techniques in order to
understand the multidrug transport mechanism. Hopefully the knowledge gained will ultimately
be useful for combatting the antibiotic resistance problem.

1

Structure-dynamics-function: the new paradigm
Structural biology has played an instrumental role in modern biology. It has generated beautiful
structures for many biomolecules, which have greatly advanced our understandings of cellular
processes and facilitated the development of modern medicine2. By solving structures of
biomolecules, one is provided the opportunity to explain sometimes puzzling phenomena and
generate structure-based hypotheses to guide future experiments. This type of structure-function
relationship study is widely acknowledged for its usefulness. The most famous case of using
structure to gain mechanistic insight is the structure of DNA double helix3 which immediately
suggests the semiconservative replication mechanism4 by which DNA is replicated in all known
cells, one of the most fundamental questions in biology. Even today, it is common a new
structure may provide novel insight into questions accumulated over 20 years of biochemistry.
However, life is in motion. These static structures can also be deceptive when they subtly
suggest that these molecules are solid rocks, albeit with complicated texture. In fact, biological
molecules are defined as soft materials in physics since they can be easily deformed by thermal
energy at room temperature. These molecules are not static at all; they sample ensembles of
conformations with only some captured in structural biology research. To truly understand the
workings of biomolecules it is important to capture different conformational states. Although
more difficult, understanding how biomolecules transition between different conformational
states is also important since the different modes that a specific molecule samples are subjected
to evolution along with the structures. With this concept in mind, biomolecules should better be
seen as nano-machines with defined motional modes that can extract order from the
environment.
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There are already exciting studies on biomolecular dynamics, which signal the importance of this
field. For example, systematic studies of the whole catalytic cycle of DHFR have identified key
substates along with characterization of interconversion rates between different substates5-7.
Armed with these beautiful structures, populations (thermodynamics), and rates of
interconversion (kinetics), a movie can be constructed to watch biomolecules work in action!
Another example where protein dynamics play a key role is allosteric signaling. Since proteins
exist in an ensemble of conformations, large scale domain motions provide the physical basis for
signal transduction through protein-protein interactions in the nanoscale8. In the case of RNA,
which is known to be highly dynamic and whose dynamics are encoded by intrinsic properties of
RNA structures and external environmental factors, it is not surprising to learn that RNA
molecules can both carry genetic information and perform a wide variety of functions9. Even for
DNA, they can sample many more conformations than simply being just straight double helices
as generally assumed10,11. The emerging theme for biomolecules is that much of the functional
complexity lies not only in the intricate details of the 3D structures but also in their ability to
sample distinct conformations.

Transporters are inherently dynamic.
Most progress in the field of protein dynamics has occurred in studies of soluble proteins.
Despite the key role of membrane proteins in controlling the information and material flow
between cells and the environment and their importance as drug targets, membrane protein
dynamics research is limited. This is in part because it is still technically challenging to work
with membrane proteins. Due to the hydrophobic nature, membrane proteins need to be purified
in a solubilizing environment, e.g. in detergent, which should maintain their native states. A
3

great deal of trial-and-error is still needed to screen for conditions that can generate useful
research materials in the first place. Only in the last decade has structural biology of membrane
proteins exploded. Exciting new structures of membrane receptors, ion channels, and transporters
are being published, which is paving the way for dynamic studies to provide the next level of
insights into understandings of mechanism and function of these important biomolecules.
Membrane transporters are an important family of membrane proteins that are inherently
dynamic. As membranes are needed so life forms can separate self from environment, this
necessitates biological machineries that reside in the membrane to relay signals and selectively
import nutrients and export wastes. As a result, there are many membrane transporters in cells to
move molecules in and out, and malfunctions of transporters are implicated in various
diseases12,13. Membrane transporters, like enzymes, are inherently dynamic entities as required
by their functions. In order to transport substrates across the membrane, transporters need to bind
substrates and switch between at least two conformations, one outward-facing and one inwardfacing. So in the case of transporters, the linkage between structure and dynamics is critical for
proper function. They cannot be completely understood solely on the basis of static structures,
even if these structures are of high resolution. Therefore, membrane transporters are an exciting
new frontier to study structure-dynamics-function relationships.

Alternating access in transport
Initial attempts to understand transport processes proposed a “moving carrier” model14. In this
model, carriers bind substrates and then move across the membrane before releasing the
substrates on the other side. Now, we know that the moving carrier model may account for
4

transport processes carried out by ionophores like valinomycin. But for protein transporters
which are integral membrane proteins, our current understandings of membrane and protein
structures suggest that such a model would have energetic barriers that are prohibitively high.
Our mechanistic understandings of transport cycles now are defined by the alternating access
model. In this model, transporters have at least two conformations, one outward-facing and one
inward-facing, and alternate between these two conformations to expose the substrate binding
site to one side of the membrane and then the other15-18. In the presence of transporters, the
permeability barrier for substrates imposed by the membrane is no longer fixed. Instead, as the
transporter alternates conformations, the permeability barrier moves shifting to the closed side of
the transporter. As a result, the alternating access model was also called the “moving barrier”
model in early literature. This model has been so successful to describe biochemical observations
of transport processes that it dominates the field today.
The alternating access model is conceptually compelling and useful since diverse transport
processes can be categorized based on minor modifications of the basic concept involved.
Transport processes can be divided into active transport and passive transport (known as
facilitated diffusion) based on whether an energy source is needed or not. In facilitated diffusion,
no energy is consumed and thus the direction of transport is always down the concentration
gradient of the transported substrate(s). Uniporters are involved in facilitated diffusion. To
complete the transport cycle, uniporters will need to alternate the binding site from one side of
membrane to the other both in the presence and absence of substrates. One example of uniporters
is the family of glucose transporters, where significant breakthroughs in structural understanding
were recently achieved19-21.

5

In active transport, substrates are transported against their concentration gradients using some
source of energy. In primary active transport, as in the large family of ABC transporters, ATP
molecules are consumed to fuel the conformational changes required for the alternating access
and to drive substrates against their concentration gradients. Thus metabolic energy stored in
ATP is transformed into the chemical potential of the transported substrates. Secondary active
transport, also known as cotransport or coupled transport, instead relies on the energy stored in
an electrochemical potential to drive transport. The “downhill” movement of one substrate,
usually H+ or Na+, is used to fuel the “uphill” movement of another substrate. Secondary active
transporters can be further classified into symporters and antiporters, depending on whether the
transported substrates move in the same or opposite directions (Fig. 1.1). In symport, both
substrates cross the membrane in the same direction. Mechanistically, symport is explained
through alternating access of the substrate-binding site on the transporters only when either all
coupled substrates are bound or when the binding site is empty. The alternating access of the
binding site cannot happen when only one substrate is present; otherwise the cotransport would
be decoupled. In contrast, in antiport, the substrates move across the membrane in opposite
directions, and the coupling is traditionally explained by (i) requiring strict competition between
the substrates for a single binding site so only one substrate can bind at a time and (ii) allowing
alternating access only when one substrate is bound but not when the antiporter is in the apo
state.

6

A

B

Fig. 1.1 Secondary active transporters can be classified into symporters (A) and antiporters (B). The transporters are
represented in green and two different substrates are represented as a yellow sphere and a lavender hexagon.

In the alternating access model, the conformational interconversion, during which transporters
switch between outward-facing and inward-facing conformations, is central to the transport cycle.
It is at this step that transporters reorient substrate binding sites from facing one side of
membrane to the other and substrates are translocated across the major permeability barrier.

7

Understanding how the binding of substrates to transporters is linked to transport is deeply
related to understanding how the conformational interconversion occurs at an atomic level.
As a result of the large scale conformational changes involved in the conformational
interconversion process, the movement of substrates across the membrane by transporters is
much slower compared to channels. Ion movements through channels can be as fast as diffusion
since channels can be viewed as holes in the membrane that have complex regulations of their
opening and closing. The topological constraints set by transporters in active transport are
necessary for them to transport substrates against their concentration gradients using an energy
source. This could never be realized by a pore-like structure as in channels.
As discussed, the transport process is an inherently dynamic process. In this thesis, I focused on
the conformational interconversion process in transport, in the hope of providing deeper
understanding of the physical basis of the transport mechanism.

EmrE: a model system
EmrE is a small multidrug resistance transporter in E. coli that utilizes the proton-motive force
across the inner membrane to efflux polyaromatic cationic antibiotics. Due to its small size,
EmrE has been extensively studied as a model system for membrane protein folding and
insertion22, membrane protein topology23,24, membrane protein evolution25,26, and proton-coupled
antiport27. In addition, it is implicated in bacterial antibiotic resistance and biofilm formation28,29,
making it potentially clinically relevant as well. Yet, after more than 20 years of studies using a
variety of methods ranging from molecular biology to biophysics, our mechanistic understanding
of EmrE is still rather immature30.
8

One example of how this seemingly “simple” model system turns out to be rather complicated is
illustrated in the controversy related to the structure and topology of EmrE27,31. The sequence of
EmrE has 110 amino acids, and the hydropathy analysis of EmrE immediately (and correctly)
suggested four transmembrane helices32. However, it took several lines of studies to establish
that the functional unit of EmrE is an antiparallel dimer33-37. Looking back, several layers of
complexity made the topology of EmrE controversial for a long time. In essence, all the major
obstacles are a result of our rather primitive understandings about membrane proteins. The first
major obstacle lies in the biochemistry involved in purifying EmrE. Earlier studies of EmrE used
organic solvents which are now known to disrupt the native state of EmrE as manifested in a
weaker affinity to TPP+38,39, a commonly used EmrE ligand. Also some bulky tags used for
purification of recombinant EmrE turned out to affect the membrane insertion and topology25,40,
further complicating data interpretation. Finally, EmrE is among the earliest examples of dual
topology, where a membrane protein with no particular charge bias in the loop regions can insert
into membrane without preference of a particular orientation. This was totally unexpected given
the understanding of membrane protein synthesis and insertion at the time and led to great
skepticism of initial reports of antiparallel topology, despite their appeal due to homology with
larger transporters23-25,33,34,40.

9

Fig. 1.2 Available experimental structures for TPP +-bound EmrE. A. A cryoEM electron density map from 2D
crystallography (7.5 Å resolution) at a contour level of 59.7. Image from EMDataBank (EMD-1087). EmE was
purified in DDM and crystallized in DMPC bilayers. B. A model based on cryoEM map and evolutionary
conservation. Image from PDB (2I68). TPP + is not shown. C. The X-ray crystal structure (PDB: 3B5D). Image from
Chen et al., 2007. EmrE was purified and crystallized in N-nonyl-β-D-glucoside (NG). To properly reflect the lowresolution nature, only Cα atoms were deposited. D. Ribbon representation of the EmrE-TPP+ X-ray structure
docked into the EM density map, contoured at 1.2 σ. The TM helices are labeled and the two monomers are
distinguished by asterisks. Image from Chen et al., 2007.

Structural evidence supporting the antiparallel dimer structure came from cryoEM33,37,41 and Xray34 studies (Fig. 1.2), although both are of moderate resolution. The cryoEM structure of EmrE
in complex with TPP+ showed for the first time that the functional unit of EmrE is an asymmetric
dimer with six transmembrane helices forming the ligand binding chamber37. This discovery was
independently supported by X-ray structures from another group34. Follow-up studies from the
10

Tate group in collaboration with Nir Ben-Tal33 considering the evolutionary conservation of each
helix and the pseudo two-fold symmetry between the two monomers insightfully proposed that
the antiparallel dimer could switch between outward- and inward-facing conformations if the two
monomers simply swap conformations. This predicts the two structures of EmrE open to
opposite sides of the membrane are structurally the same. Immediately, this model could
reconcile the structural asymmetry in the dimer with functional symmetry suggested by bulk
biochemical data. Further dynamics studies (Fig. 1.3) using high-resolution solution NMR,
single-molecule FRET, and cross-linking studies lent overriding support for this elegant model35.
Additional in vivo experiments confirmed the antiparallel dimer topology in the native E. coli
environment36,42, and the mechanism of antiparallel dimer formation has recently been
established22.
These structures are instrumental to establish the topology of EmrE. However, due to the
moderate resolution and the dynamic nature of EmrE, only Cα atoms coordinates were deposited
for both the cryoEM and X-ray structures. How is the TPP+ ligand coordinated in the binding
pocket? How could substrates binding lead to the conformational interconversion that lies at the
heart of energetic coupling? In order to progress towards answering these mechanistic questions,
higher resolution structures are needed.

11

Fig. 1.3 Conformational interconversion in EmrE. A. Conformational interconversion for antiparallel, asymmetric
EmrE: the two monomers swap conformations and the outward- and inward-facing states have identical structures
except for which aqueous compartment is accessible to the transport pore. The two structures are related by a 180˚
rotation about an axis that is parallel to the bilayer and perpendicular to the page. The measured interconversion rate,
kconf, is ~5 s-1 at 45˚C. B. Chemical shift difference between the two monomer conformations plotted onto the
antiparallel dimer model (left) or an overlay of the two monomers with transmembrane helices 1-3 aligned to
compare the two monomers within the antiparallel dimer (right). Figure from Morrsion et al., 2012.

NMR is an ideal tool for determining a better structure of
EmrE.
High-resolution structures of transporters facing either side of the membrane provide a great deal
of insights into the transport mechanism. These structures will directly reveal how substrates are
coordinated in the binding pocket, and which interactions need to be disrupted in inward-facing
conformation and then rebuilt in outward-facing conformation as the transporter interconverts
12

between states. Such high-resolution structures of transporters in different states are challenging
to obtain. Our previous NMR studies revealed that drug-bound EmrE has the same structure in
outward- and inward-facing conformations. So by determining the structure of drug-bound EmrE,
we can get both outward- and inward-facing states. This structure will identify substrate
coordinating interactions and shed light on the coupling mechanism between substrate binding
and conformational exchange. This long-sought high-resolution structure of EmrE will serve a
defining role in integrating all the available data to understand the mechanism and guide future
experimental design in the field.
However, the conformational plasticity that enables EmrE to transport diverse drugs also makes
it a very challenging system for high-resolution structural studies. This dynamic nature of EmrE
and lack of soluble domains hamper the formation of well-packed crystals for X-ray and also
prevents high-resolution structure determination by cryoEM. The same considerations lead to the
failure of alternative methods for crystalizing membrane proteins by inserting soluble domains or
using crystallization antibodies. Thus, NMR spectroscopy is the best approach for EmrE
structure determination. Structure determination by NMR is one major area of research (and Kurt
Wuthrich was awarded the 2002 Nobel chemistry prize for developing NMR techniques for
structure determination of biomolecules). However, although NMR can accommodate some
dynamics, it needs a relatively static structure for NOE measurement (long mixing time).
Inspired by the success of thermal stabilization by point mutations in GPCR crystallography43,44,
we collaborated with Chris Tate at Cambridge to screen and select EmrE mutants with preserved
ligand binding but loss of function with hope that these will reflect loss of dynamics.
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NMR provides a dynamic description of the EmrE
alternating access process.
As transport is inherently a dynamic process, a dynamic view is needed to provide a necessary
link between static structures and functional transport. NMR spectroscopy is a well-established
technique to study protein structure and dynamics simultaneously under a variety of conditions.
In fact, the most unparalleled application of NMR is its power to study dynamics.
There are a collection of NMR dynamics experiments to study motions at different timescales
(Fig. 1.4). The dynamic information provided by these experiments is derived from relaxation
time measurements45,46. In NMR, relaxation means the return of a spin system to its equilibrium
following a perturbation. The rate of return depends on the time-dependent magnetic fields the
spin is experiencing. Since local magnetic field fluctuates as a result of molecular motions, the
relaxation of spin systems can be linked to dynamic information.
Macromolecules typically tumble in the nanosecond timescale, so motions that are much faster
or slower than tumbling time can be detected. Motions faster than nanosecond timescale are
usually studied using 15N T1, 15N T2, and 1H-15N NOE experiments. Motions in the microsecondto-millisecond timescale could be studied using T1ρ and CPMG experiments while motions in the
millisecond-to-second timescale could be studied using ZZ-exchange, NOESY, and real-time
NMR experiments47.
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Fig. 1.4 Protein dynamics and NMR dynamics experiments. A. Free energy as a function of an arbitrary
conformational coordinate. The free energy landscapes of proteins are very rugged with multiple minima.
Fluctuations between different local minima have barriers of varying heights that translate into a wide range of
timescales. B. Typical timescale ranges for different types of protein motions. C. NMR experiments that can be used
to study dynamics on different timescales. Figure adapted from Ferella, et al. 2012.

Chemical shift is one very sensitive NMR observable that could report on dynamics of molecules.
When a nucleus is exposed to different chemical environments as the molecule samples different
conformations, chemical shifts of that nucleus in the resulting NMR spectrum could provide
information about both population (thermodynamics) and exchange rates (kinetics). Based on
comparisons between exchange rates and chemical shift differences, this is usually divided into
slow-exchange regime, intermediate-exchange regime, and fast-exchange regime. The resulting
spectra in different categories have different appearances (Fig. 1.5).
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Fig. 1.5 The time regime of chemical exchange in NMR is defined by the relative magnitudes of k ex and Δν. The
effects of varying kex are demonstrated on the one-dimensional NMR spectra with P A = 75%, PB = 25%, and Δν =
100 Hz. In the slow exchange regime (kex << Δν = ΔωAB/2π), two separate peaks are observed for the two states
reflecting their distinct chemical shifts, intensities, and linewidths. In the fast exchange regime (kex >> Δν =
ΔωAB/2π), only one signal is observed with population-weighted averages of chemical shift, intensities, and
linewidths. At intermediate exchange regimes, the linewidth is increased due to exchange broadening. Figure from
Ferella, et al. 2012.

Our dynamics studies of EmrE focus on the conformational interconversion process, which
occurs in the millisecond-second timescale. So ZZ-exchange experiments are the main dynamics
experiment used to characterize different mutants of EmrE and EmrE with different substrates.
ZZ-exchange is used to characterize the kinetics of interconversion between different
conformational states in the slow exchange regime48. It is based on multidimensional chemical
shift correlation experiments with the addition of a mixing time between indirect and direct
16

dimension frequency detection. During the mixing time, the magnetization is aligned along the Z
axis, parallel to the magnetic field. If conformational exchange happens during the mixing time,
there will be additional cross-peaks from exchange in the spectrum. The kinetic exchange rates
could be extracted by recording a series of ZZ-exchange experiments with varying mixing time.
Homonuclear NOESY experiment could be seen as the simplest ZZ-exchange experiment, and
exchange cross-peaks are also observed in NOESY spectra of WT EmrE35.

Fig. 1.7 A schematic representation of ZZ-exchange spectroscopy for a 1H-15N spin pair exchanging between two
states. ZZ-exchange is useful for studying dynamics in the slow exchange regime where state A (red) and B (blue)
give rise to separate peaks in NMR spectra. During the mixing time T, magnetization is aligned along the Z-axis,
parallel to the static magnetic field. When T = 0, this experiment gives rise to two auto-peaks at (ωN,A, ωH,A) and
(ωN,B, ωH,B) for the two states. When T is long enough for measurable exchange to occur, A to B and B to A
conversions during the mixing time lead to two additional cross-peaks (magenta) at (ωN,A, ωH,B) and (ωN,B, ωH,A).
The dependences of the peak intensities on mixing time can then be analyzed to yield chemical exchange rate
constants.
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Molecular dynamics (MD) simulation is another major technique that can reveal a great deal of
dynamic information about biomolecules. These “computational microscopes”49 could deliver
unparallelled all-atom descriptions about the dynamics of biomolecules. However, these
simulations are based on imperfect force fields, and the timescale involved here is several orders
of magnitude longer than could be afforded by currently available computing resources. So a
combination of both experiment and modeling is needed. Through collaboration with the lab of
Emad Tajkorshid (University of Illinois at Urbana-Champaign), we have also integrated
molecular modeling and molecular dynamics (MD) simulations to complement our solution
NMR studies of EmrE structure and dynamics.

Scope of Thesis
This thesis uses mainly solution NMR to characterize the structure and dynamics of EmrE in
atomic detail. Chapter 2 summarizes efforts to identify and characterize EmrE dynamics mutants
suitable for structure determination. Chapter 3 describes efforts toward a high-resolution
structure of EmrE in complex with drug using solution NMR spectroscopy. Chapter 4
investigates a series of mutants with different ligands to elucidate the role of helix kinking in
conformational interconversion. Chapter 5 reports the asymmetric features of the EmrE Ctermini that have largely been overlooked to date. By correlating high-resolution structural and
dynamic data with data from functional transport assays, this thesis investigates the multidrug
transport mechanism of EmrE. The new insights enrich our understanding of the key properties
controlling proton-driven drug efflux in EmrE and set the stage for understanding even more
challenging transporters.
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Chapter 2: Search for putative dynamics
mutants
Introduction
The transport cycle of a transporter requires several structural states. EmrE is a proton-coupled
antiporter; therefore, there are at least three structural states in terms of ligand binding: drugbound, proton-bound, and the true apo state. In our structural studies of EmrE, we focus on the
drug-bound state. This drug-bound state is the most studied; and there are two low-resolution
structures available1,2, significantly lowering barriers involved in solving a membrane protein
structure using NMR. Also, with the drug occupying the binding site, there is reduced amide
exchange3 useful for long NMR experiments. For the ligand we focus on TPP+, which is the
mostly commonly used ligand for EmrE. The affinity of EmrE for TPP+ is in the nanomolar-tomicromolar range4, making a fully ligand-saturated state easy to achieve. This avoids potential
complications from ligand binding equilibrium with a low-affinity binder.
The constant conformational interconversion of EmrE poses a significant challenge for NMR
structure determination of EmrE. This is a problem for any NMR experiments long enough to
allow cross-peaks from conformational interconversion to build up. For example, NOESY
experiments, to measure NOEs, the major class of structural restraints, necessitate the use of
really long mixing times (up to a few hundred milliseconds). But for TPP+-bound WT EmrE, the
interconversion rate is ~5 s-1 in our NMR conditions4. Thus, cross-peaks from conformational
interconversion build up long before NOEs peaks appear, seriously complicating data
interpretation. This was experimentally verified4 – exchange cross-peaks were visible with
NOESY mixing times as short as 25 ms for TPP+-bound WT EmrE at pH 7, and mixing times
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long enough to measure NOEs resulted in identical NOE observations for both monomers due to
the extensive exchange occurring during the mixing time effectively averaging the two states.
Inspired by the success of thermal stabilization by point mutations in GPCR crystallography5,6,
we collaborated with the lab of Chris Tate (MRC Laboratory of Molecular Biology, Cambridge,
UK) to screen and select for putative dynamics mutants of EmrE. The Tate lab constructed a
library of EmrE mutants containing V, A, or G at each position and then screened these mutants
using dilution plate assays7 and [3H]-TPP+ binding assays8. Mutants that displayed good ligand
binding but loss of function were selected with hope that these mutants would reflect loss of
dynamics.
I went on to further characterize these putative dynamics mutants identified in the screen. I used
an in-cell drug export assay9 to evaluate the ethidium bromide export capabilities of cells
expressing EmrE mutants. This assay provides a more nuanced readout on mutant transport
activity by monitoring the kinetics of ethidium efflux over short periods of time, whereas
dilution plating simply reflects whether drug efflux is sufficient to enable survival over 24 hours.
For mutants that indeed have impaired drug export, I then purified isotopically labeled protein to
record NMR TROSY-HSQC spectra. The ideal mutants suitable for structural studies should
maintain the overall asymmetric dimer peak pattern with favorable lineshape properties,
reflecting a stable and properly folded structure. I then performed ZZ-exchange experiments to
quantify the conformational interconversion rates4. I wanted mutants that have slower
interconversion rates than WT EmrE, since our initial goal was structure determination. I also
performed isothermal titration calorimetry (ITC) to evaluate the drug binding capabilities of
these EmrE mutants9.

26

Materials and methods
Sample preparation WT and mutant EmrE was expressed, purified, and reconstituted into
DLPC/DHPC isotropic bicelles as previously described4,9,10. Single point mutants were
constructed using QuickChange (Stratagene).
In-cell assay These assays were carried out using the BL21(DE3) strains of E. coli transformed
with empty pET15b vectors or pET15b-EmrE. The cells were grown in M9 minimal media with
100 μg/ml of ampicillin at 37 ˚C until the OD600 reached 0.4. Then cells were induced with 0.33
mM isopropyl 1-thio-β-D-galactopyranoside (IPTG) at the same temperature for 30 minutes
followed by incubation with 2.5 μM ethidium bromide and 40 μM carbonyl cyanide pchlorophenylhydrazone (CCCP) for an hour to load ethidium bromide into the cells. The cell
cultures were then stored on ice until assays were complete. For each experiment, 2 ml of cell
culture was spun down and immediately resuspended in 1 ml fresh M9 media with 2.5 μM
ethidium bromide. Fluorescence of ethidium bromide was monitored with an excitation
wavelength at 545 nm and emission wavelength at 610 nm. The time course of fluorescence was
plotted after normalization to the initial value of each run.
NMR spectroscopy NMR data were collected on samples containing 0.8-1.5 mM 2H/15N EmrE
in 20 mM potassium phosphate, 20 mM NaCl, 8-10% D2O, pH 7 at 45 ˚C on a Varian 700 MHz
spectrometer with a room temperature probe. For TPP+-bound EmrE, 1-2 mM TPP+ was added
to saturate EmrE. 2D 1H/15N TROSY-HSQC and TROSY-selected ZZ-exchange experiments11
with a lipid flip-back pulse4 were carried out with a recycle delay of 2 s and 128-144 increments.
The conformational interconversion rate, kconf, was determined from the ZZ-exchange data as
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previously described12 using the composite peak ratio method with an 11.1 ms time offset to
account for the back-transfer time in the pulse sequence9. All NMR spectra were processed with
NMRPipe13 and analyzed in CcpNmr Analysis14.
Isothermal titration calorimetry All isothermal titration calorimetry (ITC) experiments were
performed with EmrE reconstituted into DLPC/DHPC (q = 0.33) isotropic bicelles in 20 mM
potassium phosphate, 20 mM NaCl, pH 7, 45 ºC. All ITC experiments were performed on a TA
instruments LV Nano calorimeter. Data were fit simultaneously to a model of ligand binding to n
independent and identical sites plus a constant which is used to represent the baseline of bicelle
mixing9.

Results and discussion
Putative dynamics mutants from screening Chris Tate’s lab identified and provided us with the
first batch of seven putative dynamics mutants from the comprehensive screening (Table 2.1):
M21G, A59L, S64V, G90V, I101G, N102A, and N102V.

Figure 2.1 Locations of putative dynamics mutations in the secondary structure (left) and in monomer A of the Xray structure (right). The secondary structure figure was adapted from Elbaz et al., 2008. Glycine residues are
colored in orange and the seven mutants are in red circles.
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The locations of these seven residues (Fig. 2.1) can be categorized into three regions that may be
important in conformational interconversion. Residue M21 lies at the end of TM1, with one M21
at the bottom of the binding pocket while the other is above the binding pocket due to the
asymmetric dimer architecture of EmrE. This residue is located in the same TM helix as E14, the
residue responsible for proton binding. A59 and S64 are close to the 65GVG67 TM3 kink region,
which is important for conformation interconversion and multidrug recognition from cryoEM
and NMR studies1,4,9,15,16. Like M21, A59 lies at one end of a TM helix where it transitions into
the loop region. G90, I101, and N102 are located in TM4, the dimerization domain of EmrE17,18.
In TM4 of EmrE, there is a knobs-into-holes motif where glycine residues (90/97) from one
monomer pack against Leu/Ile residues (93/94) from the other monomer.

Table 2.1 Growth phenotype summary from dilution plate assays for V/A/G mutants of EmrE. Residues
in each transmembrane helix (TM) are labeled with the helix number in the TM column. Three different
substrates and two different concentrations (low and high) of drug substrates were screened: methyl
viologen (50 and 200 μM), acriflavine (116 and 463 μM), and ethidium bromide (EtBr, 400 and 1500 μM).
Symbols: ++, similar to WT EmrE; +, growth on higher concentrations of substrates, but weak; +/, only growth on lower concentration; -, no growth. Another set of dilution plate assays7 by

Mchaourab lab for a library of single Cys mutants is also shown for comparison in the last
column. The column labeled KD lists the TPP+ affinities of EmrE mutants tested.

Amino
acid
N2
N2
N2
P3
P3
P3
Y4
Y4
Y4
I5
I5

TM

1

1

1

Mut
Val
Ala
Gly
Val
Ala
Gly
Val
Ala
Gly
Val
Ala

Methyl
viologen
++
++
++
++
++
++
+
+
+
++
++

Acriflavine

EtBr

++
++
++
++
++
++
+
+
+
++
++

++
++
++
++
++
++
+
+
+
++
++
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KD (nM)

Mchaourab Cys mutantsgrowth on 507 μM EtBr

Grew at 1/10 diln

Grew at 1/10 diln

I5
Y6
Y6
Y6
L7
L7
L7
G8
G8
G8
G9
G9
G9

1

1

1

1

A10
A10
A10
I11
I11
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1

1
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E14

1
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V15
V15
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1
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1
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-

Ala

nd

nd

nd

Gly

-
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Grew at 1/1000 diln

Grew at 1/10 diln

Grew at 1/1000 diln

No growth for Cys
mutant

No growth for Cys
mutant
Negative
control

Grew at 1/1000 diln

No growth for Cys
mutant

No growth for Cys
mutant

Grew at 1/1000 diln

Grew at 1/1000 diln

K22
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F23
F23
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Characterization of putative dynamics mutants I went on to characterize these putative
dynamics mutants, and evaluated whether they are indeed dynamics mutants suitable for our
structural studies. Unexpectedly, most of the seven mutants identified have faster
interconversion rates. For example, the mutation M21G indeed reduces the rate of drug export by
EmrE as assessed from our in-cell export assay (Fig. 2.2). However, the TROSY-HSQC
spectrum (Fig. 2.3) for TPP+-bound EmrE-M21G suggests that conformational exchange
between open-in and open-out in EmrE is actually faster for this mutant. Although there are still
two sets of peaks corresponding to the asymmetric dimer, there is noticeable line-broadening and
some pairs of amide resonances are collapsing together. This is confirmed by the ZZ exchange
experiment and the rate is around 10-15 s-1. This is also true for the EmrE-A59L mutant since the
broadening of peaks due to exchange is more pronounced suggesting even faster interconversion.
Some of the observed line-broadening may also arise from structural heterogeneity and the peak
positions are slightly shifted, suggesting that there may be reduced asymmetry in these mutants.
Together these results suggest that these mutants may destabilize packing of the loops needed to
define the asymmetric closed-on-one-side structure of EmrE. This would explain enhanced
exchange and greater structural heterogeneity. Incomplete closure of the transport pore would
also lead to substrate leakage and prevent active efflux.
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The mutants in TM4 (I101G, N102A, and N102V) have faster interconversion as inferred from
the TROSY-HSQC spectra, possibly through disruption of the interface between the TM4
dimerization motif and the TM3 kink region important for open-in and open-out exchange. This
might be true for G90V as well, although most likely this mutation disrupts the dimerization of
EmrE in the first place17, as shown by the reduced number of peaks visible in the spectrum.
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Fig. 2.2 Ethidium export properties for cells expressing EmrE mutants from in-cell assay. In each subfigure, the WT
control was performed the same day. There is an additional control in lower left subfigure for D84G (WT-2).
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Fig. 2.3 TROSY-HSQC spectra for TPP+-bound EmrE in DLPC/DHPC (q = 0.33) bicelles. Spectra were collected at
45˚C on a Varian 700 MHz spectrometer with a room temperature cryoprobe.

38

Identification of EmrE-S64V as a slow dynamics mutant One mutant, EmrE-S64V, had the
desired behavior with reduced conformational interconversion and consequently better NMR
spectral quality (Fig. 2.4). Using ITC, I confirmed the TPP+ binding affinity of EmrE-S64V is
largely the same as WT. So the reduced drug export from the in-cell assay for this mutant is not

WT
S64V

HSQC
ZZ 200 ms

15N

ppm

due to impaired drug binding and likely arises as a result of slow transport across the membrane.

WT: 445 nM
S64V: 510 nM
1H

ppm

Fig. 2.4 EmrE-S64V is a slow dynamics mutant. The binding affinity from ITC for TPP + for EmrE-S64V is similar
to WT. The conformational interconversion rate is 1.2 ± 0.2 s-1 for EmrE-S64V in complex with TPP+ in
DLPC/DHPC (q=0.33) bicelles at 45˚C.

A more complete characterization of EmrE-S64V is demonstrated in Chapters 3 and 4. The
conformational interconversion rate of EmrE-S64V in complex with TPP+ (0.6 ± 0.1 s-1 in
DMPC/DHPC bicelles and 1.2 ± 0.2 s-1 in DLPC/DHPC bicelles) makes NMR structural studies
of EmrE possible.

5

As an alternative approach, we also tried to pursue the structure of WT EmrE in complex with
DPhTPP+ (0.4 s-1 in DLPC/DHPC bicelles)9, a substrate that slows the open-in and open-out
exchange rate of EmrE. However, EmrE-S64V is structurally more rigid or homogenous as
evidenced from the sharp peaks in TROSY spectra. This results in higher quality NMR spectra
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and more feasible structure determination for S64V-EmrE bound to TPP+ than WT-EmrE bound
to DPhTPP+ even though both systems have the same rate of open-in to open-out exchange. We
therefore pursued NMR structure determination using the S64V mutant, and further explored the
effects of S64 mutation to better understand the factors controlling the dynamics of EmrE critical
to its transport activity.

Conclusion
A better structure of EmrE is needed to understand the multidrug transport process of EmrE.
However, dynamics due to the conformational interconversion between open-in and open-out
make high-resolution structures of EmrE challenging for all structural approaches. The
conformational interconversion needed to be reduced in order to solve the structure of EmrE
using solution NMR. Through a collaborative comprehensive screening, we have identified
EmrE-S64V as a slow dynamics mutant suitable for structural studies. We have also explored the
importance of S64 in EmrE to gain insight into the mechanism coupling substrate binding and
conformational exchange between open-in and open-out to better understand how EmrE
performs active drug efflux.

Author contributions
This work was collaboration between Katherine A. Henzler-Wildman lab and Chris G. Tate lab.
Samantha Wynne from Tate lab collected the dilution plate assay data and provided the seven
putative dynamics mutants. Katherine Henzler-Wildman did the mutagenesis work. Chao Wu
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further characterized these mutants and identified EmrE-S64V as a slow dynamics mutant
suitable for structural studies.
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Chapter 3: Structure determination of EmrE
by NMR
Introduction
Structure determination by NMR spectroscopy relies on multidimensional NMR experiments
performed on samples labeled with 13C and 15N stable isotopes (plus 2H for large systems) to
determine resonance frequencies of nuclei in the protein1. This resonance assignment step is
necessary for further studies of the structure (and dynamics). To determine the 3D structure,
conformational restraints are then collected which usually consist mainly of proton-proton
distance restraints and dihedral angles restraints. These conformational restraints are integrated
with physicochemical knowledge of protein structures in the force field to calculate final
structures.

Resonance assignment
NMR assignment experiments can be grouped into two major categories: through-bond
experiments and through-space experiments. In through-bond experiments, connectivities are
established between nuclei linked by covalent bonds. For example, triple-resonance (1H/13C/ 15N)
backbone-walk experiments correlate nuclei in neighboring residues through scalar couplings
and are the most commonly used experiments for backbone resonance assignment. The
sensitivities of different experiments depend on the transfer efficiencies, which are related to the
scalar coupling constants (Fig. 3.1). These backbone-walk experiments greatly simplify spectral
analyses due to their simplicity since often only one or two peaks are associated with a root
resonance. Highly deuterated proteins can be used for backbone-walk experiments, making them
suitable for backbone assignment of large systems with the constraint that only experiments
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beginning on HN can be used because the other protons have been replaced by deuterium. Thus,
the out-and-back HNCACB must be used instead of CBCANH.

Fig. 3.1 Scalar coupling constants in proteins. Figure from Ferella et al., 2012.

COSY (Correlation spectroscopy) and TOCSY (Total correlation spectroscopy) experiments,
which are used mainly for side chain assignment of small proteins, belong to another major class
of through-bond experiments. In COSY experiments, cross-peaks between pairs of vicinal
protons arise due to 2J and 3J scalar couplings (protons that are connected by more than three
bonds give no cross-peaks since 4J and above are close to 0). In TOCSY experiments,
magnetization is transferred to the entire spin system of an amino acid by successive scalar
couplings. So in addition to cross-peaks that appear in COSY spectra, there will be cross-peaks
corresponding to interactions of protons connected by more than three bonds. The challenge for
using these experiments in large systems lies at the tricky balance between the need for
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deuteration and detectable protons. The fast relaxation of signals in highly protonated systems
prevents the use of many coherence transfer steps, and the use of deuteration eliminates
detectable protons.
Assignments can also be aided by through-space experiments. In through-space experiments,
dipolar couplings of nuclei occur as a result of spatial proximity and are independent of the
presence of chemical bonds between them. In nuclear Overhauser effect spectroscopy (NOESY)
experiments, cross-peaks for pairs of protons within 5-6 Å are observed. These connectivities in
space provide tertiary restraints, but may also help in sequential resonance assignment due to the
short-range nature of NOE peaks. This is especially useful in regions containing secondary
structures2. NOESY data is used more often to aim resonance assignment in large systems to
resolve ambiguity due to peak overlap, and assist in regions where backbone-walk experiments
have lower sensitivity since the coherence transfer experiments based on scalar couplings suffer
from shorter transverse relaxation times in high molecular-weight systems. In NOESY
experiments, however, magnetization is stored along the Z axis therefore the slower longitudinal
relaxation is in effect and good quality spectra can be obtained for larger systems. However, care
must be taken since NOE spectra contain peaks due to not only short-range intra and interresidue but also medium- and long-range contacts.

Structural restraints
The major sources of structural restraints for NMR structure determination are distance restraints
derived from NOEs between nearby hydrogen atoms. NOE distance restraints are crucial to
define the overall protein fold. However, as the NOE only reports information about local
structural features, a large number of NOEs are needed to reconstruct the overall structure3.
Unfortunately, it is more difficult to collect enough NOE restraints to determine the structure for
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larger systems due to ambiguity arising from resonance overlap, inability to fully assign side
chain resonances, and simple lack of side chain data due to deuteration.
Additional NMR conformational restraints are often used in addition to NOEs to assemble the
3D structure. Backbone dihedral angles, useful structural restraints to define secondary structure,
are determined from the backbone resonance assignment using amides, CA, CB, and CO
chemical shifts by comparing the chemical shifts to those of short stretches of peptides in a
database using TALOS-N4. Residual dipolar couplings (RDCs) rely on the reintroduction of a
residual alignment (~0.1%), so the molecules still tumble quickly to obtain high-resolution
solution NMR spectra, but are aligned just enough to measure residual anisotropic information,
such as dipolar coupling, to obtain orientational restraints. The key advantage of RDCs is that
these orientational restraints are measured relative to the common molecular frame and are thus
good complements to NOE distance restraints which may accumulate errors in the process of
assembling local structural features5.
Early NMR structure determinations of small proteins used distance geometry (based on a large
amount of NOEs) to calculate structures. For large systems, NMR data alone would not be
enough to determine all the atomic coordinates in the molecule. During structural calculation,
usually a primitive force field is used where the ideal covalent structure is maintained and only
the steric repulsion is active. Then all the NMR restraints are converted into energetic potentials
to guide the structure calculation towards energetic minimums. NMR structure determination
from resonance assignment to structural calculation is a highly iterative process as restraints are
incorporated and structures refined.
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Methyl labeling – an approach to overcome the challenges of large proteins
NMR is one of the three major techniques, the other two being X-ray and cryoEM, that could
lead to high-resolution structures of biomolecules. In fact, NMR-derived structures account for
10% of the PDB archive. However, an NMR-derived structure is not an image of the molecule in
the sense that an X-ray structure is. Rather, the process of structure determination using NMR is
to assemble a lot of indirect structural evidences into 3D structures3. So as the molecule gets
larger and more complicated, NMR structure determination becomes significantly more
challenging. This is one major reason why most of the structures solved by NMR tend to be
small (Fig. 3.2). Besides, for solution NMR, large molecules tumble slowly in solution. This
leads to a fast decay of NMR signals therefore low signal-to-noise ratio and low resolution of
resulting peaks. Meanwhile, the large number of signals present severe peak overlap problem in
NMR spectra. So structure determination by NMR is challenging for systems larger than 25 kDa.
One strategy for overcoming the challenges of studying large systems by NMR is the use of
methyl labeling. Isotopic labeling of methyl groups of Ile, Leu, and Val residues provides a nice
opportunity for side chain resonance assignment and restraints collection for high molecularweight systems by introducing a limited set of protons to provide distance restraints within an
otherwise highly deuterated molecule. Due to the fact that the three protons of each methyl group
are equivalent as a result of the rapid rotation around the threefold axis, NMR experiments on
methyl groups deliver high sensitivity and favorable relaxation properties even for really high
molecular-weight systems6. Also methyl groups tend to localize to the hydrophobic cores of
proteins so they are excellent reporters of structures and dynamics, especially for soluble
proteins. The linearized labeling scheme, where only Ile-δ1 and one of the two methyl groups of
Leu and Val are 13CH3-labeled using α-ketoacids, paved the way for NMR assignment
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experiments designed to link methyl groups to Cα/Cβ/C’ or even to NH, which usually are
already assigned from backbone-walk experiments7.

Fig. 3.2 NMR structure determination is challenging for membrane protein systems. Left, the molecular weight
distributions of structures solved by NMR, X-ray, and cryoEM. Figure from Ferella et al., 2012. Right, the
distributions of integral membrane protein structures solved by NMR (both solid-state and solution NMR) according
to the number of unique transmembrane helices (TM). The statistics was based on drorlist on membrane protein of
known structure by NMR as of Apr. 15th, 2015.

Challenges of NMR structure determination of membrane proteins
Currently, there are fewer than 200 membrane protein structures that have been solved by NMR,
as a result of the following factors. First of all, membrane protein biochemistry is difficult, which
is why there has only been a burst of membrane protein structures determined in last decade by
any structural method. Second, membrane proteins need a membrane-mimetic environment to be
folded and functional. Thus, even a small membrane protein behaves as a large one due to the
overall size of the protein-micelle/bicelle/nanodisc/lipodisq complex, and all the challenges
involved in solution NMR studies of large systems apply. Alpha helical integral membrane
proteins belong to an even more challenging subclass, because the chemical shift dispersion is
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generally limited and there are fewer long-range tertiary interactions available to define the 3D
structure. Solid-state NMR spectroscopy has made great advances in the last decade and can be
used to determine the backbone fold of membrane proteins in a lipid bilayer8,9. However, peak
overlap and limited side chain data still present challenges, as in solution NMR approaches.

Challenges involved in NMR structure determination of EmrE
There are additional layers of difficulty in the NMR structure determination of EmrE. Although
EmrE has only 110 amino acids in the primary sequence, the functional unit is an antiparallel
dimer. So in the structure of EmrE, the number of unique transmembrane (TM) helices is eight
which is daunting (Fig. 3.2) considering only five integral membrane protein structures with 6 or
7 TM helices have been solved thus far using NMR approaches10-14. What is more, although the
two monomers assume different conformations in the asymmetric dimer of EmrE, the two sets of
TM helices give similar NMR signals in many places, complicating resonance assignment. While
these increase the difficulty, there is a final major hurdle that makes NOE-based structure
determination of WT EmrE in complex with TPP+ not feasible: the constant conformational
interconversion of EmrE between open-in and open-out states. This conformational
interconversion process, occurs at 5 s-1 in our NMR conditions, so cross-peaks from
conformational interconversion will build up in the NOESY spectra with a much shorter mixing
time than necessary for NOE build up and measurement (up to a few hundred ms). Therefore, we
focused on solving the structure of the S64V mutant of EmrE where it is possible to get useful
NOE distance restraints due to its reduced rate of conformational exchange.
In what follows, I summarize our efforts towards a better structure of EmrE using the S64VEmrE bound to TPP+ in bicelles.
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Materials and methods
Protein expression and purification EmrE was expressed, purified, and reconstituted into
isotropic bicelles as previously described15-17 with some modifications. When OD600 was close to
0.9-1.0, IPTG was added into cell cultures which were cooled down on ice18. This was found to
increase EmrE yield. During the detergent extraction stage, the membrane fraction from the first
high-speed spin was solubilized with 40 mM decylmaltoside (DM, Anatrace) overnight to
increase protein extraction by detergent for high yield samples.
Sample preparation NMR data, unless stated otherwise, were collected on samples containing
0.8-1.5 mM EmrE in DMPC/DHPC bicelles (q = 0.33) with a protein to DMPC molar ratio of
1:50-100 at pH 7, 45 ˚C. Samples also contained 100 mM MOPS, 10-30 mM NaCl, 2 mM
TCEP, and 8-10% D2O. The use of 100 mM MOPS instead of the previously used 20 mM
phosphate buffer provided higher pH buffering capacity crucial for long time NMR experiments,
and also reduced the conductivity of solution boosting the NMR sensitivity using cryoprobes19.
For TPP+-bound EmrE, 1-2 mM TPP+ was added to saturate EmrE20.
2

H,15N samples for 2D TROSY-HSQC, ZZ-exchange experiments, H/D exchange, and

temperature titration were isotopically labeled by growing cells in D2O M9 media supplemented
with 2 g/L glucose, 1 g/L 15NH4Cl, and 0.5 g/L 2H,15N ISOGRO (Sigma-Isotech).
2

H,15N samples for water accessibility experiments had 0, 1, or 5 mM paramagnetic gadobenate

dimeglumine15.
2

H,15N samples for pH titration were prepared similarly but the final buffer system was 20 mM

acetate, 50 mM MOPS, and 50 mM bicine to buffer across a broad range of pH21.
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A 2H,13C,15N backbone-walk sample was prepared from D2O M9 media containing 1.5-2 g/L
2

H,13C glucose, 1 g/L 15NH4Cl, and 0.5 g/L 2H,13C,15N ISOGRO. This sample was reconstituted

into D54-DMPC/D22-DHPC bicelles with extensively deuterated acyl chains.
1-13C amino acid selective labeling samples were produced by growing cells in D2O M9 media
supplemented with 1.5-2 g/L glucose, 1 g/L 15NH4Cl, and 0.5-1.0 g/L 2H,15N ISOGRO. Before
IPTG induction, each 1-13C amino acid was added into the media and incubated for 15-30
minutes. For each amino acid labeling, cell cultures were supplemented at least four fold of the
amount of that amino acid present in ISOGRO22. That is: glycine (240 mg/L with 1 g/L 2H,15N
ISOGRO), alanine (260 mg/L with 1 g/L 2H,15N ISOGRO), valine (300 mg/L with 1 g/L 2H,15N
ISOGRO), leucine (104 mg/L with 0.5 g/L 2H,15N ISOGRO), isoleucine (200 mg/L with 1 g/L
2

H,15N ISOGRO), and tyrosine (39 mg/L with 0.5 g/L 2H,15N ISOGRO). None of these amino

acid labeling samples resulted in significant scrambling.
A 50% randomly deuterated 15N sample was prepared by growing cells in ~50% deuterated M9
media supplemented with 2 g/L glucose, 1 g/L 15NH4Cl, and 0.5 g/L 2H,15N ISOGRO.
A 50% randomly deuterated 13C,15N sample was prepared by growing cells in ~50% deuterated
M9 media supplemented with 2 g/L 13C glucose, 1 g/L 15NH4Cl, and 0.5 g/L 13C,15N ISOGRO.
The sample was reconstituted into D54-DMPC/D22-DHPC bicelles.
A 1H,13C,15N sample was prepared by growing cells in H2O M9 media supplemented with 2 g/L
1

H.13C glucose, 1 g/L 15NH4Cl, and 0.5 g/L 1H,13C,15N ISOGRO. The sample was reconstituted

into D54-DMPC/D22-DHPC bicelles. The final sample was in D2O based buffer.
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A Methyl-CHD2 sample was prepared by growing cells in H2O M9 media supplemented with 2
g/L 2H,13C glucose23, 1 g/L 15NH4Cl, and 0.5 g/L 1H,13C,15N ISOGRO. The sample was
reconstituted into D54-DMPC/D22-DHPC bicelles.
A methyl protonated I(δ1 only), L(13CH3,12CD3), V(13CH3,12CD3), U-[2H,13C,15N] ILV sample
for methyl assignment was prepared by growing cells in D2O M9 media supplement with 2 g/L
2

H,13C glucose, 1g/L 15NH4Cl, and 0.2 g/L 1H,13C,15N ISOGRO. Before the induction, 120 mg/L

alpha-ketoisovaleric acid (1, 2, 3, 4-13C4, 99%; 3, 4’, 4’, 4’-D4, 97-98%) and 70 mg/L alphaketobutyric acid (13C4, 98%; 3, 3-D2, 98%) were added into the media7. The sample was
reconstituted into D54-DMPC/D22-DHPC bicelles. 2 mM deuterated TPP+ was added to saturate
EmrE.
A 1-13C glucose sample was prepared by growing cells in H2O M9 media supplement with 2 g/L
1-13C glucose24, 1g/L 15NH4Cl, and 0.5 g/L 13C,15N ISOGRO. The sample was reconstituted into
D54-DMPC/D22-DHPC bicelles.
A 2-13C pyruvate alternate labeling25 sample was prepared by growing cell in H2O M9 media
supplemented with 3 g/L 2-13C pyruvate, 1 g/L NaH13CO3, and 1 g/L 15NH4Cl. For pyruvate
labeling, the pH of media needed to be closely monitored and adjusted before induction. The
sample was reconstituted into D54-DMPC/D22-DHPC bicelles.
Samples for measuring residual dipolar couplings under the isotropic condition were prepared
similarly and loaded into a Shigemi tube as most samples. For the aligned condition, the same
sample was pH adjusted and then soaked into stretched polyacrylamide gels generated using a
simple gel press apparatus (New Era)26. Briefly, the gel chamber was cleaned using nitrogen gas
and parafilmed on the bottom. Then 1 ml of newly prepared 3.8% polyacrylamide gel solution
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(2.1 ml 3.8% neutral gel: 1.306 ml H2O, 0.572 ml 1.25 M pH 6.6 bis-tris buffer, 0.2 ml 40% 19:1
acrylamide/bis solution, 12 μl 10% ammonium persulfate, 10 μl 10% TEMED) was added into
the chamber and 0.2 ml isopropanol was placed on top to avoid air contact. The gel was allowed
to polymerize overnight before it was washed with water twice, the final buffer twice, and water
twice again. Then the gel was cut on a piece of parafilm to a desired length (0.4-0.5 cm for 400
μl sample) and transferred to a petri dish which was coated with 100 μl silicone oil to reduce the
contact between the gel and the surface. The gel was carefully rotated several times and let dry
for a day. Then the dried gel was placed in the chamber with bottom parafilmed and the sample
was added into the chamber (the final protein to long-chain lipid ratio was 1:50 which was
critical for successfully soaking the protein-bicelle sample into the gel for alignment). The
soaking process took at least one day. After the soaking was done, the gel press apparatus was
assembled and the gel was loaded into an open-ended sample tube (connection from bottom to
top: sample tube – funnel – chamber – piston (o-ring on top) – cap – piston driver). Then the
piston driver was used to push the gel into the tube. After most of the gel was loaded, the
chamber was unscrewed and the gel was further pushed into the tube by pipetting with 1 ml tip.
At last, the bottom of the tube was sealed with an end-plug and a plunger was inserted on top.
NH RDC sample was prepared by growing cells in D2O M9 media supplement with 2 g/L
glucose, 1g/L 15NH4Cl, and 0.5 g/L 1H,15N ISOGRO.
NC’ RDC sample was prepared by growing cells in D2O M9 media supplement with 2 g/L
2

H,13C glucose24, 1g/L 15NH4Cl, and 0.5 g/L 2H,13C,15N ISOGRO.

NMR spectroscopy and data analysis NMR data were collected at 45 ˚C on a Varian 700 MHz
spectrometer with a room temperature probe unless otherwise noted. All NMR spectra were
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processed with NMRPipe27 and analyzed in CcpNmr Analysis28. Non-uniform sampling (NUS)
was used to increase both resolution and sensitivity for all 3D experiments29. Possion gap
sampling30 was used to generate sampling schedule (10-50% sampling density) for NUS data
collection and IST31 and NESTA32 were used for spectral reconstruction from NUS data. All
NOESY exchange used a mixing time of 150 ms to allow cross-peaks to build up while avoiding
peaks from conformational exchange.
For backbone assignment, TROSY-HNCA and TROSY-HNCACB backbone-walk experiments
were collected on a 2H,13C,15N labeled sample on a Varian 800 MHz spectrometer with a
cryoprobe at NMRFAM. A TROSY-selected ZZ-exchange spectrum with a 200 ms mixing time
was acquired for a 2H,15N EmrE sample in DLPC/DHPC bicelles (kconf is 1.2 s-1) and used to
facilitate assignment of each pair of exchange-related amides. For each 1-13C amino acid
selective labeling in a 2H,15N background, 2D TROSY-HSQC, a ZZ-exchange plane with 200 ms
mixing time, and the 1H-15N plane of TROSY-HNCO were taken. A series of TROSY-HSQC
spectra were also taken using 2H,15N samples for pH titration (4.5-9.0), temperature titration (1545 ˚C), gadobenate dimeglumine titration (0-5 mM), and H/D exchange.
For methyl assignment, a methyl protonated ILV sample was used to collect a series of 3D
experiments to link methyl groups of ILV residues back to assigned Cβ, Cα, C’, and NH groups7.
In addition, a time-shared 3D C, N-HMQC-NOESY-TROSY and 3D C, N-HMQC-NOESYHMQC were collected. All experiments involving methyl groups here used selective pulses on
the methyl proton to reduce lipid signal contamination (mostly from the non-deuterated head
groups of the lipids). These experiments were collected on a Varian 800 MHz spectrometer with
a cryoprobe at NMRFAM.
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For residual dipolar couplings (RDCs) measurement, we used intensity-based methods to
measure RDCs for NH and NC’ bond vectors since for large systems spectral overlap forbade
frequency-based methods. We used ARTSY33 for NH bond RDCs measurement. For both
isotropic and aligned condition, the reference and attenuated spectra were collected in an
interleaved manner. The delay T was set to 10.75 ms for the isotropic condition and 9.5 ms for
the attenuated condition. For each condition, both reference and attenuated spectra were
processed using the same script. The peak list from the reference experiment was used to find
corresponding peak locations in the attenuated experiment. The peak intensity ratios of the two
spectra were used to calculate coupling constants. RDCs were calculated from the difference
between coupling constants of the isotropic and aligned experiments.
NC’ RDCs were collected using a TROSY-based J-modulation method34. Due to the much
smaller NC’ J coupling constants, a series of modulation points were needed to more precisely fit
the coupling constants. For both isotropic and aligned conditions, the modulation time points 10
ms, 50 ms, 70 ms, and 90 ms were used. For each time point, both reference and attenuated
spectra were processed using the same script. The peak list from the reference experiment was
used to find corresponding peak locations in the attenuated experiment. The peak intensity ratios
of the reference and attenuated experiment at different modulation time points were used to fit
coupling constants. The NC’ RDCs were calculated as differences between fitted coupling
constants from the aligned and isotropic conditions. These experiments were performed on a
Varian 900 MHz spectrometer with a cryoprobe at NMRFAM.
The 50% randomly deuterated 15N sample was used to collect a 3D 15N-NOESY-TROSY
spectrum. This was collected on a Bruker 900 MHz spectrometer with a cryoprobe at the
University of Minnesota.
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The 1H, 13C, 15N sample was used to collect a 3D NOESY-HSQC (carbon aliphatics), a 3D
NOESY-HSQC (carbon aromatics), a 3D HCCH-TOCSY, and a 3D CCH-TOCSY experiment.
These were collected using a Varian 800 MHz spectrometer with a cryoprobe at NMRFAM.
The 50% randomly deuterated 13C, 15N sample was used to collect a 3D NOESY-HSQC (carbon
aliphatics), a 3D NOESY-HSQC (carbon aromatics), a 3D HCCH-TOCSY, and a 3D CCHTOCSY experiment.
The methyl CHD2 sample was used to collect a 3D NOESY-HSQC (carbon aliphatics), a 3D
NOESY-HSQC (carbon aromatics), a 3D NOESY-TROSY, and a 3D CCH-TOCSY
experiments.
The 1-13C glucose sample was used to collect a 3D NOESY-HSQC (carbon aromatics) and a 3D
filtered/edited NOESY-HSQC for aromatic assignment and protein-ligand NOE collection.
Preliminary Xplor-NIH structure calculations were performed to evaluate the restraints needed
for structure calculation. TPP+ force field parameters were generated using ACPYPE35.
Molecular Dynamics Flexible Fitting and Molecular Dynamics Due to the approximately 4 Å
resolution in the available crystal structure, only Cα positions are reported. The positions of the
Cα atoms form the TPP+-bound crystal structure (PDBID: 3D5D) were used to restrain a model
of EmrE generated using a combination of PSFGEN and MODELLER, effectively using the
available Cα positions as a template as the side chain and backbone shake out any instabilities.
However, the initial structure lacked α-helical secondary structure throughout the hydrophobic
transmembrane regions of the protein. Furthermore, the crystal structure placed a number of
proline residues in the loop regions between helical domains, rather than as helix terminators
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where they are far more commonly found. Thus considerable effort was initiated to use available
experimental information and other membrane protein trends to refine the model to better
approximate the in vivo state. Besides the crystal structure, there is also a cryoEM based model
available, as well as the original electron density used to construct the model. This cryoEM map
was combined with Molecular Dynamics flexible Fitting (MDFF) 36-38, where additional forces
added to molecular simulation attract atoms to areas of electron density, to refine the initial
structural model. This was achieved through two broad steps, simulation of the naked protein in
a high-dielectric (ε = 80) implicit solvent model, and embedding this model into an atomistic
membrane representation for further relaxation with additional electron density restraints. This
split was done so that the large structural changes required could be done interactively. After the
large structural changes were achieved, further equilibration was carried out in a membrane
environment.

Results and discussion
My efforts towards a better structure of EmrE are presented in three main sections: backbone
assignment, side chain assignment, and structural restraint collection. But structure determination
of macromolecules using NMR is an iterative process, and spectral analyses of all three parts
were done simultaneously.
Backbone assignment We have used a non-standard assignment strategy to combine backbonewalk data with ZZ-exchange, amino-acid specific labeling, solvent accessibility, and backbone
NOESY data to achieve a near complete backbone assignment. That is, we have assigned 98.1%
(206/210) amides, 98.6% (217/220) Cα, 92.8% (182/196) Cβ, 96.8% (213/220) C’.
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The backbone assignment was initiated using a perdeutrated 13C, 15N sample to record TROSYHNCA, TROSY-HN(CO)CA, and TROSY-HNCACB spectra. The use of perdeutration and
TROSY experiments for this slow tumbling protein-bicelle system are crucial to suppress spin
diffusion and retain favorable lineshape properties of spin systems. In addition, the use of nonuniform sampling29 was necessary to make all 3D experiments possible considering the long
experimental time needed as a result of low sensitivities of NMR experiments for this large
protein-bicelle system. The most sensitive pair of backbone-walk experiments, HNCA and
HN(CO)CA, were used to connect Cα(i-1) and Cα(i) resonances. The Cβ chemical shifts from
HNCACB, especially those of Ala, Ser, and Thr, provided additional clues for spin system
assignments. Cβ(i-1) data was used whenever available. The conformational interconversion that
caused a lot of problems in our NMR experiments was leveraged here for assignment as the ZZexchange peaks help identify exchange-related pairs of amides (Fig. 3.3).
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Fig. 3.3 Backbone assignment from backbone-walk and ZZ-exchange data. HNCA strips (top panel) from TROSYHNCA experiments were shown to illustrate the concept of backbone-walk for a sequence from residue 81 to 84
(QRLD) for both chains of EmrE. In addition to that, the assignment was confirmed using ZZ-exchange data
(bottom panel: red, TROSY-HSQC; blue, a ZZ plane with 200 ms mixing time). For each pair of exchange-related
amides, the next two residues suggested from backbone-walk should lead to another pair of exchange-related
amides.

We also used 1-13C amino acid specific labeling in a 12C, 15N background to generate starting
points for assignments22. This specific labeling for each amino acid used here (G/A/V/L/I/Y)
generated the following information (Fig. 3.4). First, missing peaks in the TRSOY-HSQC
spectrum of an amino acid labeled sample indicate the corresponding residue type of that peak is
the specifically labeled amino acid. Second, in the amide plane of the HNCO experiment, only
peaks from residues immediately following the labeled amino acid will appear. This amino acid
specific labeling was particularly helpful in crowded regions, and provided multiple anchor
points and information to fill gaps where Cα(i-1) peaks are missing in the HN(CO)CA.

Fig. 3.4 Backbone assignment from 1-13C amino acid selective labeling in 12C, 15N background illustrated using a
model peptide system (sequence: MGAVT). The HSQC spectrum for the uniformly 15N labeled peptide was
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illustrated in the left. The HSQC and the amide plane of HNCO spectra were shown in right for a 15N labeled sample
with 1-13C alanine selective labeling. Because of the use of 1-13C alanine, peaks from alanine residues will disappear
from HSQC. Meanwhile, only peaks corresponding to residues that are after alanine in sequence will appear in the
amide plane of HNCO experiment.

As TPP+-bound EmrE has an asymmetric architecture, we need to assign resonances to the
correct monomer. Backbone-walk data will have breaks due to Pro residues, lack of signal, or
overlap in the Cα chemical shift that provided the primary backbone connectivity. The overlap
problem is further exaggerated by the nature of NMR of α-helical membrane proteins, which
have reduced chemical shift dispersion. Therefore, ambiguity in chain assignment was a
significant problem. In addition to backbone-walk data, another major source of information for
chain assignment was from a NOESY walk using the N-N NOESY data. Taking advantage of the
α-helical secondary structure, we used NOE peaks connecting neighboring residues as another
source of reference when the chain assignment was ambiguous from available backbone-walk
Cα and Cβ data. We used water accessibility data to help chain assignment in the loop regions,
since the asymmetric EmrE is open to water on one side but not the other15. Also, while we know
that the binding site of EmrE is asymmetric, our iterative assignment gradually converged to
suggest one set of peaks corresponding to a single monomer is more involved in ligand binding
and the other set of peaks corresponding to the other monomer is sensitive to pH 21 (and other
sample condition changes). Therefore, we have used this information to revise our chain
assignment.
The backbone assignment was also facilitated from side chain methyl assignment. In addition, in
collaboration with Emad Tajkhorshid lab from UIUC, our assignment efforts were also
supported by a MDFF refined EmrE structure using both the X-ray structure and cryoEM
electron map (Fig. 3.5). Integrative assignment and modeling efforts were performed to guide
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initial resonance assignment based on assignment possibilities and identify possible errors. This
refined EmrE structure has a lot of structural features that are supported by our NMR data, and
provides a good starting structure for final structure calculation which will dramatically reduce
the sampling space.

90˚

Fig. 3.5 Structural model of EmrE constructed using MDFF. The monomer A is in blue, and the monomer B is in
red. A green sphere has been drawn on the C-terminus of each monomer to help identify the loops. Proline residues
3, 32, 55, and 86 are also drawn to highlight their important role in terminating helices in the refined model.
Structure modeled by Josh V. Vermaas in Emad Tajkhorshid lab.

Using these strategies, we have achieved a near complete backbone resonance assignment (Fig.
3.6), ensuring high confidence in the final assignment.

62

Fig. 3.6 Backbone assignment for EmrE-S64V in complex with TPP+.
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As previously mentioned, the chemical shifts from one monomer titrated more as the pH drifts
down. From our earlier studies and assignments here (and unpublished molecular dynamics
simulation studies which supports a higher pKa value for E14 in monomer B), we know that
monomer B titrates more strongly with pH (Fig. 3.7). Here I have plotted the chemical shift
differences between pH 7 and 6 for residues in both monomer A and B. Immediately, there are
two main regions in monomer B that respond to pH changes: one is near the E14 residue which
becomes protonated and the other is the TM3 kink region. While it makes sense that peaks from
residues close to E14B will titrate, the discovery that the largest chemical shift changes are from
TM3 kink region in TM3 is very interesting, especially considering the chemical shift changes
are much larger (e.g. more than 2 ppm change for G67 in monomer B) than usually seen in the
literature. This could be rationalized by ring current effect associated with movements of
aromatic residues in the binding site as well as the ligand TPP+ with its four phenyl rings. This is
mechanistically intriguing as it suggests that the protonation of E14B is coupled to the TM3 kink
region, a critical region for the conformational interconversion process as will be demonstrated
in Chapter 4.
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Fig. 3.7 Chemical shift differences between pH 6 and 7 as a function of residue number.

With the near complete backbone resonance assignment, it became clear that the C-terminus
from monomer A samples a minor state. This is evidenced by the presence of additional minor
peaks (Fig. 3.8) for residues in the C-terminus of monomer A and the loop region connecting
TM3 and TM4 in monomer B, which is on the same face of the asymmetric dimer as the
monomer A C-terminus. Arg106 from monomer A is very sensitive to the identity of bound
ligand17 as well as sample conditions. It is very clear that there is an additional minor state for
Arg106 in monomer A but not in monomer B. This is supported by molecular dynamics
simulations showing the C-terminus of monomer A is conformationally much more
heterogeneous compared to the other C-terminus of monomer B. Interestingly, one molecular
dynamics simulation shows the C-terminus of monomer A is extending into the binding site,
interacting with residue E14B. As will be demonstrated in Chapter 5, the C-terminus of
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monomer A is undergoing microsecond timescale motions in WT EmrE. This minor state might
be a general feature in EmrE that is not seen in WT spectra due to lower signal-to-noise ratio and
perhaps the difference in conformational exchange timescale.
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Fig. 3.8 The C-terminus of monomer A of EmrE samples a minor state. The set of minor peaks were shown for
residues R106 and Thr108 in the C-terminus of monomer A, as well as residues R82B and L83B in the loop
connecting TM3 and TM3 in monomer B. This minor population of the C-terminus in monomer A was also
observed in molecular dynamics simulations (work by Josh Vermaas) where R106 from monomer B would protrude
into the binding site and is conformationally more heterogeneous than that of the other monomer.

This observation of a minor state in the C-terminus of monomer A is very intriguing since it
might have a functional role. EmrE is a proton-coupled transporter, and our recent NMR data
demonstrates that it violates the long-standing single-site alternating access model and is able to
interconvert between open-in and open-out in multiple protonation states, at least under
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symmetric membrane conditions. If true, this would suggest that EmrE should leak protons,
however, proton leak measured in liposomes is slower than expected under ΔpH and not
detectable with a membrane potential. Since the C-terminus contains Arg106 and His110, it is
interesting to speculate whether it might function as a cap on the binding site to prevent proton
leakage. Movement of the C-terminus into the transport pore blocking water access would result
in these charges effectively moving partway through the membrane potential and could alter the
kinetics and thermodynamics related to the conformational exchange process39.
Side chain assignment Restraints involving side chain groups are important to define the tertiary
structure of a protein. But side chain assignment for large systems in general is very difficult.
First of all, the complete side chain assignment is impossible as a result of very low sensitivity
and severe spectral overlap. For partial side chain assignment, unlike backbone resonance
assignment, there is a major consideration for balance between the need for deuteration and
detectable protons. Higher levels of deuteration suppress spin diffusion and reduce spin
relaxation since deuterium has a much smaller gyromagnetic ratio (γD/γH ~ 1/6.5), therefore
improving both sensitivity and resolution. But the deuteration also reduces the number of
detectable protons, therefore providing fewer restraints. As a result of the high cost and limited
life of each sample, we tried a variety of labeling strategies to explore a cost-effective side chain
assignment strategy for EmrE.
We first tried a fully prototonated 13C, 15N labeled sample to test sensitivity in TPP+-bound
EmrE-S64V bicelle system. Encouragingly, we collected reasonable 2D carbon spectra for the
aliphatic region (Fig. 3.9) even for this fully protonated sample. For this sample, the
HCCH/CCH-TOCSY experiments could transfer magnetization from terminal methyl to Cβ
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position for ILV residues. However, as can be seen from the spectra, the proton dimension of
peaks are broadened as a result of 1H-1H dipolar coupling in the fully protonated sample.
We have also collected TOCSY and NOESY data for a 50% randomly deuterated 13C, 15N
labeled sample. The deuteration effectively cut off spin diffusion improving relaxation
properties. But additional complications arise from the random proton incorporation into methyl
groups resulting in a collection of different isotopomer species40. This rendered the already
crowded spectra even more problematic, therefore making it hard to initiate side chain
assignment from these data.

Fig 3.9 Constant-time carbon HSQC of the aliphatic region for 1H, 13C, 15N labeled EmrE-S64V in complex with
TPP+ at 45˚C. The spectrum was acquired on a Varian 800 MHz spectrometer with a cryoprobe.
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We then tried the Otten labeling scheme23 where proteins are expressed using 1H, 13C glucose in
100% D2O. This labeling scheme has been demonstrated to generate a cost-effective sample for
methyl group assignment of proteins up to 50 kDa. This labeling scheme produces proteins that
have highly deuterated Cα and Cβ, and ~50% CHD2 for terminal methyl groups. As a result of
the high level of deuteration at Cα and Cβ positions, magnetization can be transferred along the
side chain without much loss to the terminal methyl groups. Only CHD2 labeled methyl groups
are selected for detection so the spectrum looks relatively clean (Fig. 3.10). But the CHD2
detection in the pulse sequence reduces the sensitivity. This is on top of the already reduced
effective concentration of useful methyl isotopomer species. Again, these set of data provide
useful restraints but could not be used to initiate side chain assignment.
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Fig. 3.10 Constant-time carbon HSQC for the methyl CHD2 labeled EmrE-S64V in complex with TPP+ at 45˚C. The
spectrum was acquired on a Varian 900 MHz spectrometer with a cryoprobe.

Using the above samples, we have collected a lot of NOESY spectra which contain many
potential distance restraints. From these efforts, we were encouraged by the signal we got from
these rather proton-rich samples of the EmrE-S64V system. However, resonance assignment
from these spectra turned out to be rather difficult and we realized that to initiate side chain
assignment we need clean specific labeling schemes where high level of deuteration is
introduced to both simply the spectra and boost sensitivity. Here I have shown the proton
distribution (Fig. 3.11) for two main categories of side chains that we have decide to focused on
for side chain assignment and structural restraints collection. One category includes ILV methyl
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groups, and the other includes aromatics residues (WYF) important for defining the binding
pocket of EmrE based on our collective NMR and modeling analysis.

Fig. 3.11 Proton distribution in EmrE important for NMR structure determination. The modeled structure using
MDFF based on cryoEM map was showed in ribbon with the ligand TPP + (magenta) shown explicitly. Methyl
groups from ILV are shown in black. Residues involved in ligand coordination in the modeled structure are shown
as well with aromatics residues in ball-and-stick.

ILV methyl assignment Isotopic labeling of methyl groups of Ile, Leu, and Val residues provides
a set of side chain resonance upon which assignment and restraints collection is still amenable to
high molecular-weight systems. For membrane proteins, despite the fact that a significant portion
of methyl groups face lipids and therefore do not provide useful restraints, there are still a large
portion of methyl groups that are very useful to define helix packing and lay the foundation for
assignment of other side chain resonances. So we made use of the ILV labeling scheme to
initiate side chain assignment.
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Fig. 3.12 Constant-time carbon HMQC for the selectively protonated ILV sample for EmrE-S64V in complex with
TPP+ at 45˚C. The spectrum was acquired on a Varian 800 MHz spectrometer with a cryoprobe.

A methyl protonated ILV sample was prepared which generated really clean methyl spectra for
Ile-δ1, Leu-δ, and Val-γ methyl groups (Fig. 3.12). We collected a series of 3D experiments to
link methyl groups of ILV residues back to assigned Cβ, Cα, C’, and NH groups7. A 3D
HMCM[CG]CB/CA experiment was performed twice; one with two C-C COSY transfer steps to
reach Cβ for Leu/Ile and Cα for Val, and the other one with three C-C COSY transfer steps to
reach Cα for Leu/Ile/Val (opposite sign for Val peaks) (Fig. 3.13 and Fig. 3.14). A 3D Ile/LeuHMCM(CGCBCA)CO and a 3D Val-HMCM(CBCA)CO were collected to link ILV methyl
groups to C’. These methyl out-and-back experiments were found to be rather sensitive even for
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this relatively large protein-bicelle system despite the pessimistic impression from limited
studies reported in literature.

Fig. 3.13 ILV methyl assignment from selective labeling using α-ketoacids. The 1H/13C constant-time HMQC of the
methyl region of a methyl protonated I(δ1), L(13CH3, 12CD3), V(13CH3, 12CD3), U-[2H, 13C, 15N] sample of EmrES64V in complex with TPP+ at 45 ˚C was collected on a 800 MHz Varian spectrometer with a cryoprobe. The
precursors used for labeling are shown: α-ketobutyrate is the precursor for Ile and α-ketoisovalerate is the precursor
for Leu and Val. Two types of assignment experiments were used for methyl assignment: methyl-detected out-andback experiments where methyl groups are linked to Cβ/Cα/C’ and amide-detected experiments where methyl
groups are linked to NH. Colors for the labeling: green, 13C; light grey, 12C and D; black, 1H; blue, 15N; red, O.
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Fig. 3.14 Carbon chemical shift distributions for ILV residues and methyl out-and-back assignment experiments
with different COSY transfer steps for the ILV sample of EmrE. The chemical shift distributions were from
generated using CcpNmr Analysis28 with statistics from RefDB41. The methyl out-and-back experiments to correlate
methyl groups to Cβ/Cα were shown in right with different COSY transfer steps (0 step, teal, HMQC; 1 step, purple,
Cβ for Val and Cγ for Ile/Leu; 2 step, green, Cα for Val and Cβ for Ile/Leu; 3 step, navy, Cα for ILV with Cα for
Val in negative sign and buried under 2 step plane).

But the chemical shift dispersions in Cβ/Cα/C’ are still limited, since for a membrane protein
system most of the ILV residues face lipids and experience very similar chemical environments.
So we also collected the amide-detected assignment experiments which were much less
sensitive, but worked unexpectedly well for this system and provided much better dispersion
through the NH plane. A 3D Ile,Leu-(HM)CM(CGCBCA)NH and a 3D Val(HM)CM(CGCBCA)NH experiments were used to link ILV methyl groups to amides.
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The matching of Cβ/Cα/C’ chemical shifts of this ILV sample to those of the uniformly
deuterated sample was difficult. This was a result of the limited dispersion in the carbon
dimension in membrane protein NMR and the multiple-bond deuterium isotope effect42.
Therefore, we recollected backbone-walk data including a 3D TROSY-HNCA, a 3D TROSYHN(CA)CB, and a 3D TROSY-HNCO using this ILV sample.
Besides these through-bond COSY-transfer type assignment experiments, several NOESY
spectra including time-shared 3D C, N-HMQC-NOESY-TROSY and 3D C, N-HMQC-NOESYHMQC experiments were collected to help the assignment process.
Using the above-mentioned comprehensive set of methyl assignment experiments, we were able
to reach complete assignment of all 30 Ile-δ1 and 24 Val-γ methyl groups. For Leu, we have
assigned 54 out of 64 methyl groups so far and the rest of Leu methyl assignment should be
possible within a week.
Our assignment for Ile δ1 methyl groups is supported by a recently published work where a
series of Ile mutants were generated to assign the δ1 methyl group by recording carbon 2D
spectra for each Ile-to-Leu mutant43. In that study, the chain assignment for these Ile methyl
groups was achieved using a mixed dimer strategy where WT EmrE was mixed with I54L (or
I62L), and the mutated monomer was found to prefer to stay in monomer A conformation. It is
worth pointing out that our assignments are more complete than what is available from the
mutagenesis work. Our NMR experiments also assigned peaks in the crowded regions and are
less susceptible to potential global peak perturbations from mutation. So far, no methyl
assignment for Val and Leu have been published for EmrE.
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Fig. 3.15 Methyl assignment for Ile of EmrE-S64V in complex with TPP+.
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Fig. 3.16 Methyl assignment for Leu and Val of EmrE-S64V in complex with TPP+.

Aromatic assignment For EmrE, aromatic groups are crucial to define the binding pocket of
EmrE and protein-ligand interactions. This could be inferred even from the low-resolution
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structure. The aromatic restraints were found to help pack TM helices in the NMR structure
calculation of sensory rhodopsin II10. Thus we have invested major resources to facilitate
aromatics assignment and restraints collection to improve the quality of final NMR structure.
There are very limited studies for aromatic assignment, especially for large systems. Assignment
experiment based on COSY transfer simply will not work as there are many transfer steps to
reach already assigned resonances. This is further complicated by the large C-C coupling
constants and large CSA of aromatic carbon. For aromatics, the assignment will be mainly
structure-based44. We will rely on information from modeled structures (Fig. 3.17) and already
assigned NH and methyl groups to facilitate aromatic assignment.

Fig. 3.17 Contact analysis between EmrE-S64V and TPP+ from molecular dynamics simulations to facilitate
structure-based aromatic assignment. The contribution of each amino acid to TPP + binding was plotted when the
E14B was negatively charged or neutral. Work from Josh Vermaas.
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We have collected a series of NOESY spectra using the protonated 13C, 15N labeled sample (Fig.
3.18). To improve both sensitivity and resolution for these aromatics, we have also tried alternate
labeling where the large one-bond C-C coupling is eliminated and provides chances for aromatic
TROSY. We have collected data using 1-13C glucose labeling45 (Fig. 3.19) and are collecting
data using pyruvate labeling25.

Fig. 3.18 Constant-time HSQC of the aromatic region for 1H, 13C, 15N labeled EmrE-S64V in complex with TPP+ at
45˚C. The spectrum was acquired on a Varian 800 MHz spectrometer with a cryoprobe.
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Fig. 3.19 Carbon TROSY of the aromatic region using the 1-13C glucose labeling for EmrE-S64V in complex with
TPP+ at 45˚C. The spectrum was acquired on a Varian 800 MHz spectrometer with a cryoprobe.

Structural restraints I have already collected many structural restraints. The assigned backbone
resonances were used to generate backbone dihedral angle restraints using TALOS-N, which will
provide a major driving force for folding the primary sequence into helices. Alongside our
assignment efforts, I have already collected a great deal of NOESY data. These include NOESYTROSY and NOESY-HSQC (for both carbon aromatics and aliphatics) for samples with
different level of deuteration. We also have C,N-HMQC-NOESY-TROSY, C,N-HMQCNOESY-HMQC which contain hundreds of restraints related to ILV methyl groups.
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Also we have used spectral filtering and editing to get protein-ligand NOE using the aromatic
assignment sample to help define the binding pocket. The NOEs in these spectra are being
assigned on the basis of the backbone and methyl assignments and the model structure in an
iterative process by Claudia Cornilescu.
In addition, I have also collected RDCs orientational restraints. RDCs contain information about
bond orientations with respect to the common molecular frame, therefore RDCs provide longrange restraints. Since the application to biomolecules, RDCs have been used to refine structures
derived from either NOE or PRE distance restraints5. Here we have measured RDCs for NH and
NC’ bond vectors.
In order to measure RDCs, the protein should be slightly aligned to generate residual alignment
of ~0.1%. Although most alignment media (including solvent-based systems, bicelles, and
phage) do not work for membrane proteins due to their incompatibility with membranemimetics, we show that 3.8% stretched acrylamide gel can be used to align the EmrE-bicelle
system. The soaking method does produce high concentration samples. Due to the osmotic
pressure of the high lipid concentration needed to solubilize EmrE, the protein to long-chain lipid
ratio has been decreased to 1:50 from 1:100. Copolymerization method did not work because of
the presence of detergent. However, polyacrylamide doped with charged derives was found to
promote the swelling process, although the measured RDCs were degenerate with those from
neutral gels.
We tried both frequency-resolved methods and intensity-based methods to get precise
measurements. Frequency-resolved experiments can directly measure the splitting as a result of
residual alignment, but the number of peaks that can be measured is limited by the line shape of
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the semi-TROSY peaks as some peaks will be broadened out due to the constructive relaxation
of dipolar coupling and chemical shift anisotropy. Intensity-based methods use TROSY peaks
primarily, and calculate RDCs from intensity ratios of a reference spectrum and an attenuated
spectrum, therefore providing more precise measurements for large systems like EmrE in a
bicelle. For both NH and NC’ RDCs measurement, we have used intensity-based methods. The
NH RDCs were measured using the ARTSY pulse sequence33 and we have over 100 high quality
orientational restraints for S64V-EmrE system (Fig. 3.19). The NC’ RDCs measurements proved
to be much more difficult as a result of the much smaller coupling constants. We got dozens of
useful restraints using an intensity modulation method34 primarily in loops where lack of regular
secondary structure makes these restraints particular useful.
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Fig. 3.20 RDCs for amide bond vectors for TPP +-bound EmrE-S64V collected on a Varian 700 MHz spectrometer
with a room temperature probe. The aligned condition was achieved using 3.8% neutral acrylamide gel.
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Conclusion
A better structure of EmrE offers the opportunity for new insight into the multidrug transport
mechanism. The conformational plasticity of EmrE, while essential for its function, makes NMR
the best structural approach to obtain a better structure. However, NMR structure determination
of a membrane transporter with eight unique transmembrane helices is highly challenging. Here
we have made significant progress towards a better structure of EmrE using a mutant with
reduced dynamics. Using the most recent cutting-edge NMR developments, we have achieved a
near complete backbone assignment and side chain methyl assignment. We have also collected a
great deal of structural restraints including NOEs and RDCs. Future integration of these NMR
data and modeling studies for final structural calculation hold great promise for a better structure
of EmrE, which will be crucial to the mechanistic understanding of this still-puzzling model
system.
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Chapter 4: Transmembrane Helix Kinking in
Conformational Interconversion of EmrE
Abstract
Transmembrane helix kinks are relatively common structural features of integral membrane
proteins such as transporters, channels, and GPCRs. These kinks are often found in functionally
important sites and act as hinges of the structural fold, which enable proteins to sample different
conformational states required by their functions. In the small multidrug resistance transporter,
EmrE, there is a kink in TM3 of one monomer but not the other in the asymmetric homodimer
structure. Due to the way EmrE interconverts between open-in and open-out states, the kinking
and unkinking of TM3 is likely central to the whole transport cycle. Understanding this
mechanism will provide insight into the physical basis of the multidrug transport process.
Here I perturb the TM3 kink region using a series of mutants and ligands, and measure the
interconversion rates for these systems using NMR. I find that mutations around the kink region
at position 64 can dramatically alter the interconversion rates over several orders of magnitude.
Dynamics data from both the mutants and the ligand series reveal the importance of
hydrophobicity in determining the conformational interconversion rate, and support the idea that
hydration around the kink region is very important for determining the rate of TM3 kinking and
the conformational interconversion necessary for transport. This is reasonable, since backbone
hydrogen bonds must break to form the kink and the energetics will depend on the effective
dielectric constant in this area. This slow-down as a result of S64V mutation is even more
dramatic in the absence of drug. The S64V mutation slows the conformational interconversion of
drug-free EmrE from > 100 s-1 (WT) to ~0.5 s-1 (S64V mutant). This same mutation also raises
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the pKa of E14, the critical residue for coupling proton import to drug export. Thus, these results
suggest the novel hypothesis that hydration provides the physiochemical basis linking proton
import and drug export, as required for proton-coupled antiport.

Introduction
A common feature in helical membrane proteins is that transmembrane helices (TM) are
frequently kinked1-6. These kinks usually locate at sites of functional importance as they provide
exposed helix dipoles for specific ligand binding and increase structural complexities needed for
diverse functions within a general fold space. In addition, these kinks act as hinge points to
facilitate conformational sampling needed for functions.
In the small multidrug resistance transport, EmrE, there is a kink in TM3 that has been
increasingly recognized as important for the conformational interconversion and multidrug
recognition7-10. During the construction of the cryoEM model based on the electron map and
sequence conservation within the Small Multidrug Resistance transporter family, a kink was
located in TM3 of monomer A in the asymmetric dimer of EmrE7. This kink in TM3 was found
to be important for the conformational plasticity of EmrE, facilitating its recognition of drugs of
different shapes and charges8. This kink is also crucial to the conformational interconversion
process central to alternating-access transport based on solid- and solution-state NMR studies9-11.
Intrigued by the location of S64V mutation, the only slow dynamics mutation identified in our
screening efforts, we set out to characterize a series of EmrE S64 mutants to probe the
interconversion mechanism of EmrE as described in this chapter.
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Materials and methods
Sample preparation WT and mutant EmrE were expressed, purified, and reconstituted into
isotropic bicelles as previously described9,11,12. Single point mutants were constructed using
QuickChange Mutagenesis (Stratagene).
In-cell transport assay These assays were carried out using the BL21(DE3) strain of E. coli
transformed with empty pET15b vector or pET15b containing WT or mutant EmrE. The cells
were grown in M9 minimal media with 100 μg/ml of ampicillin at 37 ˚C until the OD600 reached
0.4. Then cells were induced with 0.33 mM isopropyl 1-thio-β-D-galactopyranoside (IPTG) for
30 minutes at 37˚C. 2.5 μM ethidium bromide and 40 μM carbonyl cyanide pchlorophenylhydrazone (CCCP) were added and the cells were incubated at 37˚C for an
additional hour. Assays were started immediately with excess cell culture stored on ice until it
was in an assay. For each experiment, 2 ml of cell culture was spun down and immediately
resuspended in 1 ml fresh M9 media with 2.5 μM ethidium bromide. Ethidium bromide
fluorescence was monitored with excitation at 545 nm and emission at 610 nm. The time course
of fluorescence was plotted after normalization to the initial value of each run.
Isothermal titration calorimetry All isothermal titration calorimetry (ITC) experiments were
performed on a TA instruments LV Nano calorimeter. Data were fit simultaneously to a model of
ligand binding to n independent and identical sites plus a constant baseline due to mixing11. All
ITC experiments were performed at least in triplicate. EmrE was reconstituted into
DMPC/DHPC (q = 0.33) isotropic bicelles in 20 mM potassium phosphate, 20 mM NaCl, pH 7,
45 ºC and loaded into the cell at 40-60 μM for tetraphenylphophonium (TPP+) titrations and 500
μM for titration with methyltriphenylphophonium (MeTPP+) or ethyltriphenylphosphonium
(EtTPP+). TPP+ concentration in the syringe was 150-200 μM. MeTPP+ and EtTPP+
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concentrations were 2-4 mM. For these two weaker ligands, only duplicates were carried out,
therefore, the reported errors are standard error of mean (SEM). All solutions contained buffer
and bicelle concentrations matched to the protein samples.
NMR spectroscopy and data analysis NMR data were collected using samples with 0.8-1.5 mM
2

H,15N EmrE in DMPC/DHPC bicelles (q = 0.33, with a protein to DMPC molar ratio of 1:50)

and 100 mM MOPS, 10-30 mM NaCl, 2 mM TCEP, 8-10 % D2O, pH 7 at 45 ˚C on a Varian 700
MHz spectrometer with a room temperature probe unless otherwise noted. All NMR spectra
were processed with NMRPipe13 and analyzed in CcpNmr Analysis14. For the TPP+-bound
EmrE, 2 mM TPP+ was added to ensure EmrE saturation. For EmrE-S64V in complex with
weaker ligands, 10 mM MeTPP+ or 5 mM EtTPP+of ligands was added. 2D 1H,15N TROSYHSQC and TROSY-selected ZZ-exchange experiments15 with a lipid flip-back pulse9 were
carried out with a recycle delay of 2 s and 128-144 increments. The conformational
interconversion rate, kconf, were analyzed from the ZZ-exchange data as previously described16
using the composite peak ratio method with an 11.1 ms offset time, t0, to account for the backtransfer time in the pulse sequence11. The composite peak ratios of intensities of the auto-peaks
(IAA, IBB) and cross-peaks (IAB, IBA) were fit to the following equation as a function of the delay
time, t,:
Ξ(t) =

𝐼𝐴𝐵 (𝑡)𝐼𝐵𝐴 (𝑡)
𝐼𝐴𝐴 (𝑡)𝐼𝐵𝐵 (𝑡)−𝐼𝐴𝐵 (𝑡)𝐼𝐵𝐴 (𝑡)

2
≅ 𝑘𝑐𝑜𝑛𝑓
(𝑡 − 𝑡0 )2 .

(1)

For TPP+ bound EmrE, two planes were collected with different mixing times and the mixing
times were adjusted according to the conformational interconversion rate of each mutant. The
mixing times were 40, 60 ms for S64A, 100, 200 ms for S64T, and 200, 225 ms for S64V. For
S64V bound to weaker ligands, the mixing times were 40, 60, 80, 100 ms for MeTPP+ and 80,
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120, 160, 180 ms for EtTPP+. The standard deviation of individual fits was used to estimate the
error of the rates.
pH titrations of S64V drug-free EmrE were performed on a Varian 800 MHz spectrometer with a
cryoprobe using a sample prepared as described above except that ether-linked DHPC (eDHPC)
was substituted for the standard ester-linked DHPC in the bicelles. The ether-linked lipid is more
pH stable, so this substitution reduces pH drift in higher pH-samples that normally occur as a
result of lipid hydrolysis. The DMPC was not substituted to minimize the perturbation to the
protein17. To span a wide range of pH, a mixed buffer system was used with 50 mM boric acid,
50 mM bicine, 50 mM MOPS, and 20 mM acetate. The buffer system and eDHPC were
observed to have minimal effect on the NMR spectra and interconversion rates of EmrE. For the
S64V drug-free system, a single ZZ plane with a 200 ms mixing time was collected at each pH
condition to estimate the interconversion rate. As a result of the increased solvent exchange, only
limited cross peaks could be observed at the long mixing times required to monitor exchange in
this mutant. For the pH titration data, amide proton and nitrogen chemical shifts were fit
separately18 to either one or two pKa values using the following equations19,20. For the single pKa
model, the generalized Henderson-Hasselbalch equation was used to describe the chemical shift
of each residue, δ, as a function of pH:

𝛿=

𝛿𝑃 10−𝑝𝐻 + 𝛿𝐷 10−𝑝𝐾𝐴
10−𝑝𝐻 + 10−𝑝𝐾𝐴

,

(2)

where δP and δD are the chemical shift of the protonated and deprotonated state of the residue.
For the two pKa model, a generalized macroscopic model was used:

𝛿=

𝛿𝑃 10−2𝑝𝐻 + 𝛿𝐼 10−(𝑝𝐻+𝑝𝐾𝐴1 ) + 𝛿𝐷 10−(𝑝𝐾𝐴1 +𝑝𝐾𝐴2 )
10−2𝑝𝐻 +10−(𝑝𝐻+𝑝𝐾𝐴1 ) +10−(𝑝𝐾𝐴1 +𝑝𝐾𝐴2 )

,
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(3)

where δP and δD are the chemical shifts of the fully protonated and deprotonated state of the
residue, and δI is chemical shift of the intermediate singly protonated species.

Results
EmrE-S64V is a kink region slow dynamics mutant that maintains multidrug binding. From
our previous screening efforts to find dynamics mutants of EmrE suitable for structural studies,
we identified EmrE-S64V as a slow dynamics mutant. As can be seen from ethidium efflux assay
data in E. coli (Fig. 4.1), this mutation significantly impairs EmrE transport activity in its native
environment, although it still export ethidium faster than the negative control. There are several
possible origins of this behavior: impaired substrate binding, leaking or uncoupling of the
transporter due to loss of proper structure, or reduced conformational interconversion rates
between open-in and open-out states.
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Fig. 4.1 Normalized fluorescence as a function of time from in-cell assay for EmrE-S64V. Data from the black curve
were collected for E. coli cells transformed with empty pET15b vectors whereas data from the red and blue curve
were from cells with EmrE overexpression.

This impaired transport by S64V-EmrE is mostly likely not due to impaired ligand binding since
the screening process that identified this mutation selected against mutants that did not bind
ligand. I performed more quantitative binding assays to confirm this. Ethidium is a weak binding
ligand and the Kd is difficult to precisely determine. However, as determined by isothermal
titration calorimetry (ITC) for binding to a series of TPP+ derivatives, TPP+, MeTPP+, and
EtTPP+, EmrE-S64V has very similar ligand binding properties compared to WT EmrE in
general. These TPP+ derivatives were shown to have very interesting properties: both their
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affinities to EmrE and the interconversion rates of EmrE bound to these ligands vary over two
orders of magnitude11. Based on these results, it seems unlikely that the reduced ethidium export
of EmrE-S64V would arise from significantly altered ligand binding. In addition, these data
demonstrate that EmrE-S64V maintains the multidrug binding capability.

Fig. 4.2 Isothermal titration calorimetry data for EmrE-S64V binding to TPP+, EtTPP+, and MeTPP+. These ligands
differ in only one of the four phenyl rings. These experiments were performed at pH 7, 45 ˚C in DMPC/DHPC (q =
0.33) bicelles. The first data points of these titrations were omitted for fitting since it was an artifact from titrant
dilution during incubation. As a comparison, for WT EmrE in DLPC/DHPC bicelles 11, the Kd values for TPP+,
EtTPP+, and MeTPP+ are 0.45 ± 0.01, 21.8 ± 0.7, and 130 ± 20 μM.

The TROSY-HSQC spectrum (Fig. 4.3) of EmrE-S64V in complex with TPP+ is strikingly
similar to TPP+-bound WT EmrE, with two sets of peaks that is characteristic of the asymmetric
dimer structure. Thus, EmrE-S64V in complex with TPP+ remains an asymmetric dimer structure
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with an overall structure that must be quite similar to WT. There are global peak shifts in the
vicinity of the mutation, as well as some more remote chemical shift changes as a result of the
altered kink region. As observed for the WT EmrE, the TROSY-HSQC spectra of EmrE-S64V in
complex with TPP+ are also very similar in DLPC/DHPC and DMPC/DHPC bicelles confirming
that EmrE is relatively structurally insensitive to the thickness of the lipid bilayer. However, the
conformational interconversion rate between open-in and open-out drug-bound states is
significantly different. Whereas WT EmrE in complex with TPP+ interconverts at a rate of 4.7 ±
0.6 (4.4 ± 0.4) s-1 in DMPC/DHPC (DLPC/DHPC) bicelles, EmrE-S64V in complex with TPP+
has a conformational rate of 0.6 ± 0.1 (1.2 ± 0.2) s-1 in DMPC/DHPC (DLPC/DHPC) bicelles.
This data clearly shows that EmrE-S64V is a slow-dynamics mutant and that altered
conformational interconversion dynamics is the most likely cause of the reduced ethidium efflux
rate in E. coli.
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Fig. 4.3 TROSY-HSQC and ZZ-exchange spectra for EmrE in complex with TPP + at pH 7, 45 ˚C in bicelles (q =
0.33). A. TROSY-HSQC overlay for WT (black) and S64V (red) in DLPC/DHPC bicelles. B. TROSY-HSQC
overlay for S64V in DLPC (red) and DMPC (green). C. Overlay of TROSY-HSQC (red) and a ZZ plane with 200
ms mixing time (blue) for S64V in DLPC/DHPC bicelles. D. Overlay of TROSY-HSQC (green) and a ZZ plane
with 200 ms mixing time (blue) for S64V in DMPC/DHPC bicelles. Dotted boxes in C. and D. connect auto- and
cross-peaks of pairs of amides that correspond to the same residue in each monomer and the exchange peaks due to
the two monomers swapping conformations as EmrE interconverts between open-in and open-out. From the ZZ
data, the conformational interconversion rates of EmrE-S64V in complex with TPP+ are 0.6 ± 0.1 s-1 in
DMPC/DHPC bicelles and 1.2 ± 0.2 s-1 in DLPC/DHPC bicelles. As a comparison, the rates for WT EmrE in
complex with TPP+ are 4.7 ± 0.6 s-1 in DMPC/DHPC bicelles and 4.4 ± 0.4 s-1 in DLPC/DHPC bicelles11.

Characterization of S64 mutant series Our previous screening efforts for putative dynamics
mutants (Chapter 2) revealed that most of the mutations that led to impaired transport activity,
actually increased the conformational interconversion rate. S64V mutation was the only mutation
consistent with our initial hypothesis. The position of Ser64 in TM3 is quite interesting due to its
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location (Fig. 4.4 A). First, this residue is located right before the 65GVG67 motif21 which is
known to introduce a kink in TM3 of EmrE. From the cryoEM structure, this kink is only found
in monomer A7 and is shown to contribute to the plasticity of the drug binding site of EmrE,
which is important for multidrug recognition8. The difference in helix kinking between the two
TM3 in the dimer was also observed using oriented solid state NMR10. Also chemical shift
difference mapping from solution NMR data highlights the TM3 kink region as the most distinct
in each monomer of the asymmetric dimer9 and also one of the most sensitive regions to identity
of the bound ligand11. The medium resolution X-ray and cryoEM structures7,22 both suggest that
the polar Ser64 residues from both monomers are facing inside and forming interhelix contacts,
consistent with a functional role in conformational interconversion process. In addition, Ser64 is
right after Trp63 which is one of the most conserved residues in its polyaromatic cation binding
and critical for determining the substrate specificity of the transporter23. Thus, the residue at
position 64 may also be critical for linking drug binding to transport. Sequence conservation
data21 suggests that there are three other frequently occurring residues at this position: Thr, Ala,
and Val. I further characterized these EmrE S64 mutants to probe the conformational
interconversion mechanism. I also included S64A and S64L mutations to get more
comprehensive information about the role of TM3 kink in conformational interconversion.
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Fig. 4.4 Characterization of EmrE S64 mutants. A. Sequence logo for TM3 of EmrE. Figure was modified from
Elbaz et. al., 200821. Colors: green, polar; blue, basic; red, acidic; black, hydrophobic. B. Normalized fluorescence
as a function of time for EmrE WT and S64 mutants from in-cell assay data. Data from the black curve were
collected for E. coli cells transformed with empty pET15b vectors whereas data from the others were from cells with
EmrE overexpression. WT, red; S64G, olive; S64A, navy; S64T, magenta; S64V, blue; S64L, purple. C. Measured
Kd for EmrE WT and S64 mutants with the ligand TPP + from ITC and conformational interconversion rates, kconf,
from ZZ-exchange experiments. Numbers in parentheses are standard deviations. D. TROSY-HSQC spectra for
EmrE in complex with TPP+, in DMPC/DHPC bicelles at pH 7, 45˚C, for WT (red), S64A (navy), S64T (magenta),
and S64V (blue) show two sets of peaks. E. TROSY-HSQC spectra for EmrE in complex with TPP + for S64G
(olive) and S64L (purple) show only one set of peaks suggesting significantly faster conformational interconversion.

The in-cell transport assay data provides a quick overview of the ethidium bromide export
properties of cells expressing the different EmrE mutants (Fig. 4.4 B). Not surprisingly, cells
expressing WT EmrE export ethidium bromide most efficiently followed by the S64G and S64A
mutants. Cells expressing S64T-EmrE behave differently and are more transport-impaired in the
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initial stage. Cells with the two largest and most hydrophobic mutations at this site, S64V-EmrE
and S64L-EmrE, behave similarly and are the most transport-impaired. These in vivo drug export
data are interesting but only provide a rather qualitative picture about the behavior of cells
expressing EmrE. Factors like different expression, folding, and insertion levels of the various
EmrE mutants would require many additional controls to seriously compare the drug export
properties of these EmrE mutants.
I went on to characterize TPP+ binding affinities of this series of EmrE mutants using ITC to
more quantitatively evaluate differences in ligand binding properties (Fig. 4.4 C). Interestingly,
the measured Kd values for these EmrE mutants binding to TPP+ vary only slightly; all the Kd
values fall between 200-1450 nM under identical conditions. These similar drug affinities among
the various S64 mutants, along with the similarity between the binding affinities of S64V- and
WT-EmrE for different TPP+ derivatives, collectively suggest that the binding site of EmrE is
fairly plastic and perturbations to either ligands or proteins can be accommodated without loss of
affinity. Thus defects in ligand binding unlikely contribute to the observed different phenotypes.
Intrigued by the distinct phenotypes of different S64 mutations on the drug export function of
EmrE, we characterized these TM3 kink mutants using solution NMR to identify possible
dynamics-function correlations. As shown in the TROSY-HSQC spectra (Fig. 4.4 D,E) of EmrE
in complex with TPP+, WT EmrE and S64A-, S64T-, and S64V-EmrE all show two sets of peaks
corresponding to the asymmetric dimer. These mutations do not change the structure
dramatically. In the case of EmrE S64A, cross-peaks due to conformational interconversion
appear in the TROSY-HSQC spectrum indicating faster interconversion between open-in and
open-out for this mutant, on the order of 30-100 s-1. In the case of S64G-EmrE bound to TPP+,
the conformational interconversion is so fast that only one set of peaks appear in the spectrum.
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This is similar to WT EmrE bound to MeTPP+, and a rough estimate of the rate suggests that the
conformational interconversion should be faster than 100 s-1 for S64G-EmrE in complex with
TPP+. Glycine residues in transmembrane helices are known to render the helices more flexible
as a result of the larger conformational space that can be sampled by glycine backbone dihedral
angles. Therefore glycine is one of the two residues that are known to cause kinks in helices. In
light of this, the increased dynamics by the S64G mutation of EmrE (which results in a GGVG
sequence in the TM3 kink region) makes sense. Using ZZ-exchange experiments, we calculated
that the rates for mutants that still had two sets of peaks in the spectrum. The interconversion
rates for S64A and S64T are 28 ± 3 and 2.1 ± 0.3 s-1. Thus, within the mutation series, as the size
of the residue 64 in EmrE gets larger, the interconversion rates for TPP+-bound state decrease.
However, this trend does not hold for the S64L mutation. Like S64G-EmrE, the spectrum for
S64L-EmrE in complex with TPP+ has only one set of peaks and significant line broadening
suggesting significantly faster dynamics or loss of structural asymmetry or stability. Thus,
although S64L behaves similarly to S64V in the in-cell ethidium efflux assay, its behavior is
quite distinct based on the NMR dynamics data. One possible explanation is that the bulky side
chain of S64L (Leu is rare at this position in the SMR family) might not fit within the tightly
packed helix-helix interface where S64 is located and may disrupt the structure of this critical
region more generally. As pointed out previously, the conformational interconversion step is
only one of the potential rate-limiting steps in the transport cycle11 and S64L may disrupt other
aspects of the transport cycle, such as proton coupling.
Hydration around the kink region in conformational interconversion A closer look into the
thermodynamic components of different EmrE mutants binding to TPP+ reveals the importance
of hydration within the transport pore. As shown above, the free energies of binding to TPP+ do
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not change much for different S64 mutants of EmrE. However, the enthalpic and entropic
components differ significantly (Fig. 4.5 A). For S64G/A/T substitutions, both ΔH and –TΔS of
TPP+ binding vary but remain negative as for WT EmrE. However, for S64V/L substitutions, ΔS
is positive. This observed enthalpy-entropy compensation24-31, is almost universally observed in
weak interactions in water. This suggests that the different S64 mutants may result in distinct
hydration patterns around the TM3 kink region. Altered hydration in this region would affect the
conformational interconversion rate because TM3 is only bent in one monomer of the
asymmetric dimer. As EmrE interconverts between open-in and open-out states, kinking and
unkinking must occur as the two monomers swap conformations within the asymmetric dimer.
This requires breaking and rebuilding of backbone hydrogen bonds near the middle of TM3,
which is likely a relatively hydrophobic environment. Altered hydration patterns will change the
local effective dielectric constant and perturb both the thermodynamics and kinetics of hydrogen
bonding32,33.
The idea that hydration around TM3 kink region may be important for conformational
interconversion is supported when comparing interconversion rates of the closely related TPP+
derivatives (Fig. 4.5 B,C). Previously, dynamics studies11 using this series of TPP+ derivatives
revealed that the interconversion rate decreases as the ligand becomes larger and more
hydrophobic. This is true all the way from the smallest ligand, MeTPP+ (130 ± 20 s-1, in
DLPC/DHPC bicelles), to EtTPP+ (21.8 ± 0.7 s-1, in DLPC/DHPC bicelles), to TPP+ (4.4 ± 0.4 s1

, in DLPC/DHPC bicelles; 4.7 ± 0.6 s-1, in DMPC/DHPC bicelles), and to the largest, DPhTPP+

(0.4 ± 0.1 s-1, in DLPC/DHPC bicelles). These could be understood using the hydration concept:
as the ligand gets bigger and more hydrophobic, it blocks water access into the transport pore
and the TM3 kink region becomes dehydrated increasing the energetic barrier of helix kinking
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and leading to slower interconversion. This trend is also observed in S64V-EmrE with the
conformational interconversion rate decreasing from 7.9 ± 2.3 s-1 for MeTPP+, to 1.1 ± 0.1 s-1 for
EtTPP+, to 0.6 ± 2.3 s-1 for TPP+ (I did not measure the interconversion rate for EmrE-S64V in
complex with DPhTPP+ as that would require prohibitively long mixing times for ZZ-exchange
experiments). Interestingly, the calculated ratios of interconversion rates from ligand and protein
perturbations (Fig. 4.5 D) further suggest there is a shared dehydration process. For example, in
the ligand perturbation for WT EmrE, the ratio is ~6 from MeTPP+ to EtTPP+ and ~5 from
EtTPP+ to TPP+. For EmrE-S64V, the ratio is ~7 from MeTPP+ to EtTPP+. However, the ratio is
only ~2 from EtTPP+ to TPP+. This drop in ratio is also true as seen from the protein perturbation
side. For MeTPP+ and EtTPP+, the ratios are ~16 and ~20 when the protein is perturbed from Ser
to Val. The ratio drops significantly for TPP+ and is now ~8. These results lead to a shared
dehydration hydration hypothesis: increasing either ligand or protein hydrophobicity in the
transport pore near the TM3 kink will dehydrate the binding site, reduce the rate of
conformational interconversion, and reduce the rate of drug efflux. However, a limit is reached
where no more water molecules can be displaced by further increase of either ligand or protein
hydrophobicity.
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Fig. 4.5 The role of hydration in proton-driven drug efflux by EmrE. A. Enthalpy-entropy compensation in TPP+
binding to EmrE S64 point mutants ( ΔG, black; ΔH, red; -TΔS, blue). B. TROSY-HSQC spectra of EmrE-S64V in
complex with TPP+ (red), MeTPP+ (blue), and EtTPP+ (green) show no major structural changes. C. Conformational
interconversion rates, kconf, for WT- and S64V-EmrE in the presence and absence of drug. The rates for WT EmrE in
drug-free state were estimated from solid-state NMR PUREX experiments34 and our own ZZ-exchange
measurements of drug-free EmrE20. The rates for EmrE S64V in drug-free state were estimated from ZZ-exchange
data although the slow rate limits the number of cross peaks that can be quantified. D. Ratios of conformational
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interconversion rates as a result of perturbation to the protein and the bound ligand. WT EmrE systems are colored
in red while EmrE-S64V systems are colored in blue. Numbers in parentheses are propagated errors in ratios. E. A
cartoon model to explain the role of hydration around kink region affects helix kinking and unkinking in
conformational interconversion. The two TM3 helices in the antiparallel asymmetric dimer are drawn in yellow
while the rest of EmrE is shown as green blob. During conformational interconversion, one TM3 kinks and the other
straightens. When the position 64 is a serine residue, there are more water molecules around the kink effectively
lowering the energetic barrier for helix kinking and unkinking.

As the saturation trend in our ligand and protein perturbation series suggests a shared
dehydration process, we predicted that the differences in interconversion rates between WT and
S64V EmrE will be even larger in the drug-free state. This is because the substitution of the
serine with valine should displace more waters than that when the binding site is already
occupied by a large hydrophobic ligand. This prediction is borne out by comparison of the
interconversion rates between drug-free WT- and S64V-EmrE (Fig. 4.5 C). The interconversion
rate determined from solid-state NMR34 for WT EmrE in aligned DMPC/DHPC bicelles is over
100 s-1 below neutral pH at 37˚C. This is consistent with rates determined from solution NMR in
bicelles at 45 ˚C of ~50 s-1 at pH 8.8, ~75 s-1 at pH 8.4, and much faster (>100 s-1) at lower pH
values20. In contrast, the interconversion rates for EmrE-S64V in the drug-free state are much
slower. The rate is estimated to be ~0.5 s-1 across the pH range from 5.2 to 7.4.
Collectively, these interconversion rates comparisons support the hypothesis that hydration
around the TM3 kink regions may affect the rate of conformational interconversion. This is
illustrated in the cartoon model in Fig 4.5 E. During the conformational interconversion, the two
monomers in the asymmetric dimer of EmrE swap conformations. In particular, the TM3 from
monomer A is straightened from the kinked state while the other TM3 from monomer B
becomes kinked. When the 64 position of TM3 is mutated from the polar serine residue to
nonpolar valine, the region around TM3 kink region is more dehydrated which effectively
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increases the energetic barrier of helix kinking and unkinking by changing the local dielectric
constant. This could be reasoned from both a thermodynamic and kinetic point of view. A
nonpolar mutation would increase the strength of hydrogen bonding33, therefore lowering the
free energy of the ground state. Meanwhile, this nonpolar mutation would increase the effective
dielectric constant making exposing of polar groups during kinking and unkinking of helices
kinetically more difficult.
E14 pKa fine-tuning by hydration The pH titration of the drug-free state of S64V-EmrE reveal
another interesting insight into the transport process. As previously discussed, WT EmrE is very
sensitive to pH in the absence of drug. The two active site E14 residues in the antiparallel
asymmetric homodimer have pKa values of 7.0 ± 0.1 and 8.2 ± 0.320, and the rate of open-in to
open-out exchange varies from ~220 s-1 to ~40 s-1 between pH 5 and 9.534. Unlike WT EmrE, the
interconversion for drug-free S64V-EmrE is very slow (~0.5 s-1), with two sets of peaks visible
in TROSY-HSQC spectra over the entire pH range studied (4.8 - 10.5), and is independent of pH
from 5.2 to 7.4. Solvent exchange prevents the acquisition of meaningful ZZ-exchange data at
higher pH for S64V due to the long mixing times required to monitor the slow exchange process
(the faster exchange rate of WT EmrE allows shorter mixing times to be used and ZZ-exchange
data can be acquired up to pH 8.5). This dramatically different behavior was intriguing,
particularly in light of the questions regarding how EmrE couples proton import to drug efflux
given our recent findings that contradict the long-standing single-site alternating access for
coupled antiport. Our recent discoveries of asymmetric protonation of EmrE20, its ability to
interconvert between open-in and open-out in multiple different protonation states20 and the
ability to simultaneously bind drug and proton (unpublished) are all inconsistent with traditional
single-site alternating access antiport models. We have developed a kinetic model for proton109

coupled TPP+ transport using rates measured for microscopic steps within the transport cycle, but
this naturally leads to another question: if proton coupling is achieved by careful tuning of the
proton and drug transport halves of the transport cycle, how does EmrE harness the protonmotive-force to actively pump such diverse substrates, particularly since we know that the
kinetics of the open-in to open-out exchange process varies over several orders of magnitude for
the substrate transport side of the cycle?
We hypothesize that hydration provides the key, linking both substrate and proton transport by
tuning both the conformational interconversion rate and the pKa of the critical E14 residue.
Changing hydration patterns can affect pKa values and protein functions as demonstrated in
several other cases35-43. We therefore predicted that reduced hydration of the transport pore in
S64V-EmrE should further upshift the pKa values of the two Glu14 residues.
This is indeed the case and is immediately obvious from the TROSY-HSQC spectra at several
pH values (Fig. 4.6). The peaks of drug-free S64V-EmrE shift only slightly below pH 8, in stark
contrast to WT EmrE20. With the use of ether-linked DHPC, we were able to collect spectra up to
pH 10.8. At pH values higher than 8.6, significant number of peaks, especially those that are
exposed to the solvent, disappear as a result of increased amide exchange. But it is very obvious
from the residues that remain visible that two sets of peaks remain. From the curved pattern as
the peaks shift across the spectrum with pH, there are at least two protonation events. I fit the
chemical shifts as a function of pH using both a single pKa and double pKa model20. The double
pKa model clearly gives better fits to the data, as was also observed in WT20. The fitted two pKa
values, 8.6 ± 0.1 and 9.3 ± 0.2, are both at least one pH unit higher compared to WT EmrE. This
not only supports the idea that hydration in the binding site is reduced as a result of the S64
mutation, but also links the proton coupling E14 region to the TM3 kink region.
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Fig. 4.6 pH titration of EmrE-S64V in drug-free state reveals a link between hydration and fine-tuning of E14 pKa
value which is critical for energetic coupling in the transport cycle. A. TROSY-HSQC spectra at pH 5.9, 6.8, and
7.8. Colors: pH 5.9, magenta; pH 6.8, red; pH 7.8, lime; pH 8.6, bright blue. B. Regions of spectra from pH titration
show movements of peaks as the pH is increased. Upper figure, an enlarged glycine region; lower figure, a region
including Ala10. Colors: pH 5.9, magenta; pH 6.4, pink; pH 6.8, red; pH 7.1, orange; pH 7.4, yellow; pH 7.8, lime;
pH 8.1, green; pH 8.4, cyan; pH 8.6, bright blue; pH 9.0, navy; pH 9.3, lavender; pH 9.6, purple; pH 10.2, brown;
pH 10.5, grey. C. Fitting of chemical shifts as a function of pH to a single pK a (dotted lines) and two pKa values
(solid lines). Peaks are not assigned. The two pKa model fits better to the experimental data and gives 8.6 ± 0.1 and
9.3± 0.2 while the single pKa model gives 8.6 ± 0.1. As a comparison, the two pKa model fitting for WT20 give 7.0 ±
0.1 and 8.2 ± 0.3 while the single pKa model gives 7.1 ± 0.1.

Discussions
TM kinking central to interconversion As the number of membrane protein structures grows, it
is clear that kinked helices are more common than initially expected, and TM helix kinks are
usually found at sites of functional importance. Kinks commonly occur at Gly or Pro
residues2,3,5,6 and may provide the correct functional groups and geometry for ligand
coordination, or create hinge points for functionally important conformational changes required
by many membrane protein functions. Such functions include moving molecules or transducing
signals across the hydrophobic membrane barrier: transporters must alternately open to either
side of the membrane, GPCRs must transfer information from one side of membrane to the
other44, and ion channels must open and close in response to signals45.
In the case of EmrE, substantive evidence points to the importance of the TM3 kink in the
transport process7,9-11,46. Here, I show directly the importance of the TM3 kink for
conformational exchange between open-in and open-out by demonstrating that mutation of S64
leads to almost three orders of magnitude differences in the interconversion rate. For example,
the glycine at position 64 increases the interconversion rate to > 100 s-1, consistent with
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flexibility allowed by the small side chain and consequent propensity of glycine to facilitate kink
formation in helices47.
The role of hydration in helix kinking thus interconversion By comparing interconversion rates
of different EmrE mutants and WT EmrE bound to different drugs, we identified a common
theme that size and hydrophobicity of the amino acid side chain or substrate correlated with the
conformational exchange rate. Thermodynamic characterization of substrate binding revealed
enthalpy-entropy compensation, leading to the hypothesis that hydration around the TM3 kink
may be important for substrate interaction, and perhaps also helix kinking and conformational
interconversion of EmrE. As the residue at position 64 (or the substrate) gets bigger and more
hydrophobic, the interconversion between open-in and open-out slows down, although this effect
eventually plateaus. This suggests that there may be a shared dehydration process around the
TM3 kink resulting from a combination of protein and ligand factors.
Helix kinking within the hydrophobic environment of the membrane is generally unfavorable
unless water or other proteins interactions can stabilize the broken backbone hydrogen bonding
partners and lower the energetic barrier of exposing helix dipoles within bilayer. Residue 64 in
WT EmrE is serine. Serine residues in helices can stabilize a TM helix kink since the side-chain
hydroxyl group can hydrogen bond with the carbonyl group of the i - 4 residue48-50. However,
mutation of S64 to alanine increases the interconversion rate, suggesting that hydrogen bonding
potential is not a critical factor. Based on the observed pattern of effects across both mutant and
ligand, neither hydrogen bonding potential nor the presence of polar groups are critical for rapid
conformational exchange, supporting the more general hydration model.
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Furthermore, the effect of S64 mutation on conformational exchange rate is even more dramatic
in the drug-free state where the mutation is the sole perturbation, as expected from the proposed
dehydration model. While WT EmrE in the absence of drug interconverts between open-in and
open-out at rates between ~30 s-1 to > 200 s-1 in a pH-dependent manner. EmrE-S64V has a
conformational exchange rate of ~0.5 s-1 near neutral pH in the absence of drug substrates.
The hydration concept explains most of the experimental data, but it is clearly not the only factor
affecting interconversion. S64L does not fit the trend of decreased conformational exchange with
increasing side-chain size and hydrophobicity. Instead, the interconversion rate of TPP+-bound
EmrE-S64L is significantly faster even than TPP+-bound EmrE-S64A. We hypothesize that
leucine is large enough that it does not fit well in the tightly packed region of the TM3 hinge
where it interfaces with the substrate binding pocket. The interconversion rate of drug-free
EmrE-S64L is 1.2 ± 0.2 s-1, similar to drug-free EmrE-S64V and much slower than TPP+-bound
EmrE-S64L. Thus S64L is more consistent with the overall pattern in the absence of substrate,
suggesting that the binding site of EmrE, although plastic, still has limited space. Perhaps similar
factors explain the behavior of EmrE-S64V in complex with MeTPP+/EtTPP+. This is also
suggested by the global peak shifts observed between the drug-free and substrate-bound states of
EmrE-S64V.
Hydration as a unifying factor in transport In addition to the importance for TM3 kinking and
open-in to open-out conformational exchange of EmrE, hydration could also influence the
energetics of first solvent shell within the transport pore, affecting the pKa of titratable residues
important for proton-coupled transport. The various kinetic steps, e.g. drug-off rate and
interconversion rate, in multidrug transport by EmrE vary several orders of magnitude11 and pKa
shifts upon drug binding will affect the efficiency of proton-coupled transport within our new
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kinetic model for EmrE transport. The simultaneous effect of altered hydration within the
transport pore on the rate of TM3 kinking and the pKa of E14 suggests a new model for how
EmrE achieves proton-coupled transport of various drugs with different sizes, shapes, and
charges.
To date, studies of EmrE structure and dynamics have all been performed in symmetric
environments. Yet, in vivo, the membrane asymmetry brought by the negative-inside membrane
potential could be a defining feature affecting the kinetics and thermodynamics of multiple steps
in the transport cycle. Hydration within the transport pore will also influence movement of
charged residues within the pore across the membrane potential as the barrier switches from one
side of the transport pore to the other. As a result, hydration may be an important unifying factor
to simultaneously fine-tune multiple steps in the transport cycle and achieve efficient protoncoupled transport.

Conclusion
In this chapter, I presented experimental data supporting the hypothesis that the TM3 kink in
EmrE is crucial for conformation interconversion and transport activity. The perturbations of
position 64 in TM3 dramatically changed the interconversion rate by over three orders of
magnitude. Combined with the ligand perturbation series, this suggest that hydration within the
transport pore may fine-tune the interconversion rate. In addition, these changes are also linked
to more than 1 unit change of pKa values of E14, suggesting hydration may provide a key link
between substrate binding site and the TM3 kink important for open-in to open-out exchange, as
required for coupled antiport.
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Chapter 5: Asymmetric C-termini of EmrE
Abstract
EmrE, a small multidrug resistance transporter, is a model system for studying the transport
process. Sequence conservation and prior NMR data suggest that the C-termini of EmrE may be
functionally important. Unfortunately, currently available structures of EmrE lack information
about the C-termini. Here we use the highly conserved C-terminal His110 residue as a reporter to
probe the chemical environment of the C-termini in EmrE. Our results show that His110 from
the two monomers within the asymmetric dimer have different upshifted pKa values and dynamic
behaviors. These results reveal that the C-termini of the two monomers are not just flexible,
water exposed tails but interact with the rest of the asymmetric dimer, providing the first insight
into the structure and environment of the highly conserved C-terminal histidine.

Introduction
The C-terminal residue of EmrE, His110, is highly conserved,1-3 suggesting that it may be
functionally important. Other residues conserved to this degree have been shown to be critical to
function: Tyr60 and Trp63 (substrate recognition), Gly97 (dimerization), and Gly65 and Gly67
(transmembrane helix 3 hinge). However, the role of His110 remains ambiguous. One potential
role of His110 is in determining the membrane topology of EmrE due to its partial positive
charge. EmrE has very low charge bias, consistent with its dual topology in the membrane, and
addition of a single positively charged residue or multiple histidines to the C-terminus has been
shown to alter the topology of the entire protein.4 However, the contribution of His110 to net
charge bias does not sufficiently explain its conservation as the C-terminal amino acid in many

124

SMR family members since most of the other charged residues in EmrE are not highly as
conserved. This suggests that His110 may have an additional function.
A high resolution structure of EmrE could provide hypotheses for the role of His110.
Unfortunately, the conformational plasticity that enables EmrE to transport diverse substrates
also makes it a very challenging system for high resolution structural studies.5 As a result, there
are currently only low-resolution cryoEM6 and X-ray7 structures available with no structural
information on the C-terminal tail. Terminal regions of proteins are frequently missing from
crystal structures due to their dynamic nature, and NMR is an ideal technique for studying
flexible regions elusive to traditional structural approaches. Interestingly, the NMR spectra of
EmrE suggest that the C-terminal region may have a unique structure or environment.8 The
residues in this region, including 104-108, have very unique chemical shifts that are not typical
of an α-helix or a random coil, and the peaks are not as intense as they would be in an
unstructured tail.8,9
Furthermore, the NMR spectra of EmrE in complex with different substrates show that the
chemical shifts of residues 105, 106, and 108 from the C-terminal tail of one monomer in the
homodimer are very sensitive to the identity of bound substrates while the residues in the tail of
the other monomer are nearly insensitive to the bound substrate.8 Without direct structural data it
is difficult to understand this stark asymmetry. However, considering the orientation and position
of the fourth transmembrane helix in the best available structures, it is possible that the Cterminus on the open side of the antiparallel dimer might extend into the substrate binding site
while the C-terminal tail located on the closed side would be relatively isolated from the rest of
the protein. Taken together, the experimental data available to date suggest that the C-terminus
may have a functional role based on its high conservation and sensitivity to substrate identity.
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To better understand the potential function of the C-terminal tail and conserved terminal
histidine residue, we performed an NMR pH titration of the His110 side chains. These
experiments probe the pKa and dynamics of the highly conserved His110 and provide additional
insight into the environment of the C-terminus of EmrE. Histidine side chains can exist in two
neutral tautomeric states (ε and δ) and one charged state (+). Studies of model compounds have
established a set of characteristic 15N histidine chemical shifts for each of these states (Figure
S1).10-14 The protonated and deprotonated nitrogen atoms in either of the two neutral forms have
chemical shifts of 167.5 ppm and 249.5 ppm and the two nitrogen atoms in the charged state
resonate at 174 and 178 ppm. The chemical shifts of histidine side chains are readily recorded,
even in large membrane protein systems such as EmrE, using HMBC experiments where the
magnetization is transferred from the non-labile carbon 1H through 2J/3J to 15N. Rapid exchange
between the different states of the histidine side chain, as commonly observed in aqueous
solution14,15, leads to 15N chemical shifts that are a population-weighted average of all species
present. 15N chemical shifts of the histidine side chain as a function of pH can be analyzed to
determine the pKa value as well as the tautomerization equilibrium constant, KT =[δ]/[ε].13 By
comparing the pKa and KT values with those of model compounds in water (pKa of 6.2 and KT of
0.25),13 we can get insight into the chemical environment surrounding the histidine side chains.

Materials and Methods
Protein purification and sample preparation
The pET15b vector expresses EmrE with a N-terminal hexhistidine tag that can be removed by
thrombin cleavage to leave three extra N-terminal residues (GSH).7 EmrE was overexpressed,
purified, and reconstituted into DMPC/DHPC (q=0.33) isotropic bicelles as previously
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described.9,16 Briefly, BL21-DE3 cells containing EmrE expression plasmid were grown in M9
minimal media. 15N labeling media was supplemented with 2 g/L glucose and 1 g/L 15NH4Cl. 2H,
15

N labeling was grown in D2O M9 media with 4 g/L glucose, 1g/L 15NH4Cl, 0.5g/L 2H,15N

ISOGRO (Sigma Isotec), and one generic multivitamin per liter. EmrE overexpression was
induced with 0.33 mM IPTG at an OD600 of ~1.0 at 17 ˚C for ~16 hours. His-tagged EmrE was
purified in n-Decyl-β-D-maltopyranoside (Anatrace) via Ni-affinity chromatography and the tag
was removed by thrombin cleavage. The tag-less EmrE was then subject to size exclusion
chromatography (Sephadex 200) and pooled fractions were reconstituted into DMPC/DHPC
isotropic bicelles.
1

H-15N HMBC NMR spectroscopy

All NMR experiments were performed on a 700 MHz Varian NMR spectrometer equipped with
an HCN room temperature probe. 15N labeled NMR samples in DMPC/DHPC bicelles (100
DMPC lipids per EmrE dimer) containing 1.2-1.5 mM EmrE (monomer concentration) and 2
mM TPP+ were buffered by 20 mM acetate, 50 mM MOPS, and 50 mM bicine. NMR samples
also contained 10% D2O, 0.05% NaN3. DSS (4,4-dimethyl-4-silapentane-1-sulfonic acid) was
used for 1H chemical shift referencing and 15N chemical shifts were indirectly referenced.
Sample pH was adjusted using a pH electrode calibrated at the same temperature and was
measured again after each NMR experiment to account for any pH drift. pH drift during 2D
NMR experiments was only observed for titration points above pH 8 and the average pH value
was used.

Two-dimensional 1H-15N HMBC spectra of TPP+-bound EmrE were recorded from pH 5.1 to pH
8.8 at 45 ˚C using a HMQC pulse sequence. The delay during which 1H and 15N magnetizations
127

become antiphase was set to 22.8 ms so that magnetizations from 1JNH couplings are refocused.10
In the HMBC experiment, magnetizations start from non-labile carbon protons (Hε1 and Hδ2)
and are transferred through 2J/3J to 15N atoms (Nε2 and Nδ1) in histidine side chains. So, for
each histidine residue in a unique environment, there are two 1H and two 15N chemical shifts
corresponding to at most four peaks (the Hδ2-Nδ1 peaks are sometimes not seen as a result of
the smaller 3J coupling).10-12,14

Paramagnetic Relaxation Enhancement 1H-15N TROSY HSQC experiments
Four separate uniformly deuterated, 15N labeled NMR samples were prepared as described
above. Samples contained 0.6-0.8 mM EmrE monomer as well as 20 mM NaCl, 0.05% NaN3,
10% D2O, 2 mM TCEP, 2 mM TPP+, and 2 mM DSS and were buffered by 100 mM MOPS, 100
mM bicine, and 20 mM acetate. Each sample was adjusted to pH at 35°C as described for the
HMBC experiments. 1H-15N TROSY HSQC spectra were collected on each sample with a 700
MHz Varian Inova spectrometer at 35°C. Following sample acquisition, the pH was checked
again to confirm pH stability and the pH reported are averages of the pre-run and post-run pH
measurements. To assess paramagnetic relaxation effects, 0.5 mM MnCl2 was added to each
sample17-19 and another, identical, spectrum was collected in the same manner.

Spectra processing
All spectra were processed with NMRPipe20 and analyzed using CcpNmr Analysis21.

Interpretation of 1H-15N HMBC spectra
Histidine side chains exist in equilibrium between the charged state (+) and two neutral states (δ
and ε) where the two neutral states are in a tautomeric equilibrium. The protonation equilibrium
constant Ka is given by [δ+ε][H+]/[+], while the tautomerization constant KT is given by [δ]/[ε].
The recorded 15N chemical shifts of histidine side chains contain a wealth of information about
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their protonation and tautomerization equilibria since the different states have very characteristic
15

N chemical shifts10,11,13 (Fig. 5.1). In the charged state (+), both nitrogen atoms of histidine side

chains have chemical shifts at around 176 ppm; this is an α+ type nitrogen. In the neutral states
(δ and ε), protonated nitrogen atoms (Nε2 for ε state and Nδ1 for δ state) have α type chemical
shifts of 167.5 ppm while unprotonated nitrogen atoms (Nδ1 for ε state and Nε2 for δ state) have
β type chemical shifts at around 249.5 ppm. So at the low pH limit where the histidine is in the
charged state (+), the spectra from HMBC experiments will have four peaks with an α+ type
nitrogen chemical shift for both 15N atoms of a model compound.13 At the high pH limit, if there
is a preference for ε or δ, there will be both α and β types of chemical shifts and the downfield
peaks will correspond to β type nitrogens (Nδ1 or Nε2 for ε or δ preferences, respectively). If
there are both ε and δ states at the high pH limit, the measured chemical shifts will be
population-weighted averages of both states, since solvent exchange is fast in most
occasions.14,15 At intermediate pH, the chemical shifts will be population-weighted averages of
all exchanging states including the charged state (+) and the neutral states (ε and δ).
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Fig. 5.1 1H-15N HMBC peak patterns expected for different states of a model histidine side chain.

Determination of pKa and KT values from pH titration spectra
The pKa and KT were determined using a previously published method.13 Briefly, 15N chemical
shifts at various pH values are fit to the modified Henderson-Hasselbalch equation,

𝐶𝑆𝑜𝑏𝑠 = 𝐶𝑆ℎ𝑖𝑔ℎ ×

1
1+10(𝑝𝐾𝑎 −𝑝𝐻)

+ 𝐶𝑆𝑙𝑜𝑤 × (1 −

1
1+10(𝑝𝐾𝑎−𝑝𝐻)

)

(1)

where CSobs is the observed chemical shift. The chemical shifts at extreme low and high pH are
represented by CSlow and CShigh respectively. CShigh is the population-weighted average of the 15N
chemical shifts of both neutral states.
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Using the value of CShigh determined from equation (1), the proportion, P, of ε or δ states is
calculated from,

𝑃=

249.5−𝐶𝑆ℎ𝑖𝑔ℎ

(2)

249.5−167.5

using typical chemical shifts of model compounds as reference values (167.5 ppm for α type and
249.5 ppm for β type nitrogen atoms). The tautomeric equilibrium constant, KT, is given by the
following equation.

𝐾𝑇 =

𝑃(𝛿)

(3)

𝑃(𝜖)

The measured chemical shifts for both Nδ1 and Nε2 at different pH values for each residue were
fit using equation (1) with a single pKa parameter. The residue-specific KT constants were then
estimated from equations (2) and (3).

Results and discussion
We have collected twelve 1H-15N HMBC spectra from pH 5.1 to 8.8 for TPP+-bound EmrE in
DMPC/DHPC isotropic bicelles (q = 0.33). For the construct we use in our experiments, there
are three additional residues remaining at the N-terminus after thrombin cleavage: GSH.7 The Nterminal His-1 residue serves as a convenient internal control in this study. Since there are two
His residues per monomer and two monomers per asymmetric EmrE dimer, we expect to see a
maximum of four sets of peaks, assuming each histidine has only one major conformational
state. Each set will in turn be composed of at most four peaks since the magnetization can start
from either Hε1 or Hδ2 and is transferred through 2J/3J to Nδ1 and Nε2. Fewer peaks may be
observed due to weaker 3J coupling and/or dynamic exchange on an intermediate timescale. The
resonance assignments for His110 and His-1 were made by performing a similar set of pH
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titrations for a mutant with His-1 replaced by alanine (His-1Ala EmrE). Assignment to individual
monomers could not be made since His110 is preceded by Pro109, which precludes throughbond assignment methods, so the A, B designations for the two monomers within the dimer are
arbitrary throughout this chapter.
Across the pH range studied, both N-terminal His-1 residues behave like model compounds and
there is little difference between the two His-1 residues in either chemical shift or dynamic
behavior (Fig. 5.2). At pH 5.10, there are four peaks for each His-1 residue (connected with grey
lines), and the two upfield peaks from both His-1 residues have degenerate chemical shifts
suggesting they are experiencing very similar chemical environments. As the pH increases, the
proportion of histidine side chains in the neutral states will increase, causing the 15N chemical
shifts of all four peaks to move downfield. The Nδ1 peaks will move faster as long as the ε state
is the preferred neutral state, as observed here. At around neutral pH, the two upfield peaks for
the two His-1 residues remain very close. Meanwhile, both lower-right peaks (Nδ1-Hδ2)
disappear possibly as a result of increased protonation equilibria in the context of an already
small 3J coupling. The downfield movement of peaks continues as the pH increases and plateaus
above pH 8. Note that as the chemical shift differences between the Nδ1 and Nε2 peaks become
really large at pH 8.8, the peak widths increase significantly, implying that the exchange between
the two neutral states is no longer in the fast regime.
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Fig. 5.2 H- N HMBC spectra of TPP -bound WT EmrE collected on a Varian 700 MHz spectrometer with a room
temperature probe at varying pH: (A) pH 5.10 ± 0.02, (B) pH 6.87 ± 0.00, and (C) pH 8.80 ± 0.15. Peaks belonging
to His110/His-1 are labeled and connected with red/grey dotted lines. The assignments of Nε2 and Nδ1 peaks were
made by comparing relative peak intensities. A, B designations are arbitrary here. Assignments were made by
comparison with spectra of His-1Ala EmrE.
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To quantitatively estimate the pKa and KT values, we fitted the 15N chemical shifts over this pH
range using equations 1-3 as described in more detail in methods section.13 The modified
Henderson-Hasselbalch equation describes the chemical shift as a function of pH:
CS

1

high
CSobs = 1+10(pK
+ CSlow (1 − 1+10(pKa −pH))
a −pH)

(1)

where CSobs is the observed chemical shift and CSlow and CShigh represent the extreme chemical
shifts at high and low pH, respectively. Since CShigh is the population weighted average of the
15

N chemical shifts of both neutral states, the proportion of ε or δ states can be approximated by,

P=

249.5−CShigh

(2)

249.5−167.5

with reference to the ε or δ state chemical shifts of model compounds. The tautomeric
equilibrium constant, KT, is then simply
KT =

P(δ)

(3).

P(ϵ)

As can be seen in Fig. 5.3, the titration series for the two His-1 residues can be well fit. The same
results are obtained whether the two nitrogens are analyzed individually or simultaneously for
each residue. Here we only report the globally fit parameters. The two His-1 residues have pKa
values of 6.26 ± 0.03 and 6.13 ± 0.03, similar to model compounds (pKa of 6.2). The KT values
for the two His-1 residues are 0.37 and 0.33, which are also close to model compounds (KT of
0.25). Both these quantitative results and the qualitative behavior of the His-1 peaks in the NMR
spectra suggest that the twoHis-1 residues exist in a symmetric, water-exposed environment,
consistent with a flexible tail that does not interact with the asymmetric EmrE dimer.
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His110

His-1

B: Nδ1

B: Nδ1

A: Nδ1

A: Nδ1

B: Nε2
B: Nε2
A: Nε2

A: Nε2

Fig. 5.3 Histidine 15N chemical shifts as a function of pH (symbols) together with the global fitting (lines). Error
bars represent standard errors and are shown only when they are larger than the size of the symbol.

Based on recorded chemical shifts and titration behaviors, the two C-terminal His110 residues
are clearly different from His-1 and are also different from each other (Fig. 5.2). At pH 5.10, the
two His110 residues have more downfield chemical shifts compared to His-1, implying the
His110 residues are more protonated and have higher pKa values. As the pH increases,
differences between the two His110 residues become apparent. At pH 6.87, His110B still has
four visible peaks that are distinct from the other three histidines, while His110A only has two
upfield peaks visible with chemical shifts more similar to His-1. His110A completely disappears
from the spectra above neutral pH. Given that the chemical shift difference between protonated
and unprotonated 15N corresponds to 5.7 kHz on a 700 MHz spectrometer, this signal loss
suggests there are significant dynamics on a microsecond-millisecond timescale. At pH 8.80,
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well above the pKa, His110B differs dramatically from His-1 and the spectral pattern indicates
that His110B not only has a significantly upshifted pKa but also a different KT value. The fitted
pKa value for His110B is 6.82 ± 0.01, and the KT value is ~0.69 (Fig. 5.3), which indicates more
of the δ species is present in the neutral state than is typical for a model compound. The
stabilization of the δ species could come from H-bonding with any electronegative group of the
system, including the C-terminal carboxylate group.13 For His110A, as a result of a lack of data
above pH 6.87, the pKa cannot be confidently determined but is estimated to be in the range of
6.3-6.6, somewhat upshifted from model compounds. Nevertheless, both the titration behaviors
and the fitted pKa values demonstrate that the two C-terminal His110 residues are experiencing
different environments.
To get more insight into the environment surrounding His110, we measured solvent accessibility
of the backbone of TPP+-bound EmrE by determining the paramagnetic relaxation enhancement
broadening effect of Mn2+ 17-19 on the 1H-15N TROSY-HSQC across the same pH range (Fig.
5.4). At pH 5.2 and 6.0, the His110 signals for both monomers are not fully relaxed by the
paramagnetic ion, indicating they are partially protected from the solvent. However, at pH 7.1
and 8.4, the signals become fully relaxed. While it is not possible to deduce what interaction
could be protecting the backbone from solvent at low pH, this data does begin to provide an
explanation for the shifted pKa values: the protonated state appears to be interacting with either
the membrane or the protein itself. Since this technique is monitoring the backbone and is not
sensitive enough to detect minor differences, it is not surprising that we cannot see a distinction
between the environments of the two His110.
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Fig. 5.4 His110 peaks in the 1H-15N TROSY-HSQC of TPP+-bound EmrE. At each pH, spectra were collected first
in the absence and then in the presence of the paramagnetic ion, Mn 2+.

Conclusion
In summary, we have made use of the 15N chemical shifts of histidine side chains to probe the
chemical environments of the two C-termini of TPP+-bound EmrE. Our data reveal that the two
His110 residues each display a distinct dynamic behavior and both have upshifted pKa values.
This is in sharp contrast with the two N-terminal His-1 residues which behave very similarly to
each other as well as to model compounds. These findings suggest that the two C-termini of the
asymmetric EmrE dimer are not simply disordered, solvent-exposed tails, a claim which is
further supported by the observed protection from a soluble paramagnetic agent at low pH.
However, if the upshifted pKa values were simply due to stabilization of the protonated state by a
relatively non-specific interaction with the water-lipid interface, a phenomenon not uncommon
to histidines in membrane environments,22 one would expect the two histidines to display very
similar dynamic profiles and pKa values. Likewise, a simple interaction with the carboxyl groups
of each terminus should also have similar effects on both His110. The fact that the dynamics of
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the two C-termini are distinct suggests that interaction with the asymmetric EmrE dimer is likely
contributing to the unique environments of the two His110 residues. Although the data presented
here cannot speak directly to the nature of this interaction, it is interesting to note that the
timescale of dynamics which is the likely cause of signal loss from one of the two His110 is not
in the open-in to open-out conformational exchange regime9 but is of the same order of
magnitude as loop dynamics and ring flipping. Interaction with either the loops or one of the
several aromatic residues in the substrate binding site or even the substrate itself could lead to
dynamics on this timescale. As it has previously been observed that residues in one of the Ctermini are sensitive to the drug identity,8 it is tempting to speculate that one of the C-termini
may interact with the protein near the drug binding site. However, further information, such as a
high-resolution structure, will be needed to test this possibility. Nonetheless, this research begins
to reveal the environment of the highly conserved C-terminal histidine and highlights the need to
consider the role of the C-termini in future mechanistic studies.
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Chapter 6: Conclusion and Future Direction
My doctoral thesis focuses on a small multidrug resistance transporter, EmrE, which is a model
system for secondary active transporters. Despite decades of intensive studies, mechanistic
understanding about how EmrE couples proton import and drug export remains rather
immature1. This results from, to a large extent, a lack of atomic descriptions for different
structural states in the transport cycle and the dynamic processes linking these structures states,
since transport is inherently a dynamic process. Therefore, my thesis studies both structure and
dynamics of EmrE in order to provide mechanistic insights about proton-coupled multidrug
transport. This is enabled by the use of NMR, a powerful technique to study structure and
dynamics simultaneously with atomic resolution. Complemented by other techniques, our
structure and dynamics studies have made good progresses towards building a higher-resolution
structure of EmrE and understanding the physicochemical basis underlying conformational
interconversion central to transport processes in general.
We have overcome several challenges involved in NMR structure determination of EmrE. The
conformational interconversion, where EmrE exchanges between open-in and open-out, is
constantly ongoing. This makes the long-sought high-resolution structure of EmrE extremely
challenging to obtain by any structural approach. The relatively small size and constant dynamics
of EmrE make NMR the best approach for structural studies. Yet, the conformational
interconversion still poses significant problems for NMR structure determination which can only
tolerate certain levels of dynamics. Therefore, through collaborative screening, we set out to
find potential dynamics mutants and identified EmrE-S64V as a slow dynamics mutant suitable
for structural studies. Though this mutant makes NMR structure determination of EmrE possible,
this is still a highly challenging project. Current NMR structures are mostly for molecules with
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molecular-weight less than 25 kDa, and NMR structure determination of helical membrane
proteins are further complicated by signal overlap and limited tertiary restraints. Therefore,
considering the asymmetric dimer of EmrE has eight unique transmembrane helices, we have
made very good progress by assigning most of backbone and side chain methyl resonances.
These resonance assignments were only possible using the most cutting-edge technologies
including sparse sampling and specific labeling designed for large and challenging systems. This
is aided by our novel approach making use of the often challenging factors inherent to EmrE, e.g.
the use of ZZ-exchange data from conformational interconversion to assign pairs of amide
resonances in combination with backbone-walk data. Our assignment processes and mechanistic
insights are also coupled. This is reflected by the convergent chain assignment within the
asymmetric EmrE dimer aided by the pH titration data and concurrent realization that
protonation of E14 is asymmetric, causing systematic peak shifts in monomer B, which is
mechanistically relevant to proton coupling. Another beneficial factor in our assignment process
is the combination of experiment and theory through integration of our NMR data with
collaborative modeling studies. These modeling studies not only provided good starting points
for structure-based assignment, but also provided feedback on inconsistencies for refinement
during the iterative assignment process.
There are very limited NMR studies for systems as complicated as this one. My research helps
push the boundary on several frontiers of biomolecular NMR structure and dynamics of
asymmetric, dynamic assemblies and integral membrane proteins, which will be of general
interest to the broader biomolecular NMR community. I have tried various labeling strategies for
side chain resonance assignment designed for large systems with mixed success, and these
lessons will help future studies of membrane proteins, which have some distinct challenging
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features from large soluble protein complexes. For example, our strategy of initiating more
extensive side chain resonance assignment from methyl groups is broadly applicable for
membrane protein systems. However, due to the hydrophobic environment of membrane
proteins, a significant portion of methyl groups face lipids and therefore are not as valuable as
those in soluble proteins, necessitating an approach that goes beyond backbone and methyl
groups. Nevertheless, the technological advances in ILV methyl labeling provide starting point to
bootstrap assignment of other side chain resonances. Methyl groups also provide tertiary
restraints for initial definition of helix packing.
Our methyl assignments are only possible because we have collected high quality methyldetected out-and-back and amide-detected spectra. It is worth to point out that the high quality of
these methyl assignment experiments based on COSY was unexpected considering the general
pessimistic impression from the literature. This case encourages future research into this COSYtransfer route for large systems.
My work also highlights the importance of aromatic residues in NMR structure determination of
membrane proteins, which should be seriously considered for future studies. This is in part
because of the limited amount of restraints that can be collected for helical membrane proteins
due to requirements for deuteration and the fact that many methyl groups face lipids and do not
contribute long-range restraints for 3D structure determination. This is especially important
considering the controversies involved in several membrane protein NMR structures. Despite the
challenges involved, side chain restraints from methyl and aromatic groups should both be
considered for future NMR structure determination of helical membrane proteins.
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Our large sets of NOESY spectra on samples with various labeling schemes will provide a
reasonable number of distance restraints. In addition, these distance restraints are further
complemented with orientational restraints from high precision RDCs measured using strainedgel induced alignment.
To finish the structure, iterative assignment of the large sets of NOESY spectra must be
completed along with structural calculation. Structure calculations will be aided by the starting
structures from our collaborative modeling studies and the newly implemented implicit
membrane model within Xplor-NIH2. Ideally, more extensive testing of the resulting final
structures in explicit membrane environment should be performed by continued collaboration.
These modeling studies certainly will continue to offer insights and generate hypotheses for
future experimentation. For example, further NMR and MD research will likely contribute key
insights to the proton-coupling mechanism in atomic detail. How is the proton transferred within
the pore and how is this affected by the presence of drug? How does the C-terminus from
monomer A behave with different protonation states of both E14 and H110 residues? What is the
hydration pattern within the pore under different conditions? How will the presence of
membrane potential change the system?
The EmrE-S64V mutant also makes structural studies of drug-free states possible. The next
structure(s) that could be pursued should be the proton-bound state(s). After the first structure is
solved, it will be much easier to solve related structures. The help from modeling will reduce the
barrier even more as well. These structures will provide further information about the structural
basis of the proton-coupling mechanism, e.g. how EmrE avoids leaking proton even though it
can interconvert between open-in and open-out in multiple protonation states.
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Our dynamic studies of the series of S64 mutants, following the identification of EmrE-S64V,
demonstrate for the first time that mutations near the TM3 kink in EmrE alter rates of global
conformational exchanges dramatically. This provides experimental confirmation of the
hypothesis that the TM3 kink of EmrE serves a as hinge enabling global conformational
transition needed for transport activity. In addition, our characterization of the mutant series
together with the ligand series suggest a very interesting trend that the interconversion rate
decreases with increasing hydrophobicity within the pore. These data pointed me to the
importance of hydration for enabling the helix kinking and unkinking required for
conformational interconversion. What is more, the hydration concept could be more broadly
involved in the overall transport process. The S64V mutation not only changes the rate of
interconversion, but also perturbs the pKa values of E14 by more than one pH unit, suggesting
that hydration could fine tune important steps involving proton transport as well. This
observation makes hydration a unifying factor to understand the proton coupling mechanism of
EmrE. Furthermore, the multidrug transport activity of EmrE has several rate-limiting steps, e.g.
drug off-rate and interconversion rate, which are orders of magnitude different for different
ligands. Hydration could provide the underlying explanation for how EmrE achieves protoncoupled multidrug transport with such different kinetics of individual steps by simultaneously
tuning the pKa shift upon substrate binding.
Further structural characterization of the TM3 kink under a variety of conditions, combining
different substrates and kink region mutants will help develop future mechanistic insights into
the interconversion process. To get more precise measurements of helix orientation information
for EmrE, oriented solid-state NMR experiments such as PISEMA should be performed for
specific amino acid- labeled EmrE samples3.
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In order to get direct information about the hydration pattern around kink region, NMR H/D
experiments and molecular dynamics simulation for several mutants should be performed. Also
ITC experiment in H2O vs D2O4-6 would directly probe the solvent reorganization contribution
involved when comparing different mutants. Neutron scattering7 might also be helpful if changes
in hydration are significant enough. Interpretation of these experimental data will benefit greatly
from accompanying simulations that provide atomic structural and kinetic models of hydration
within the transport pore.
More studies are needed to further explore the effect of ligands and mutants on the pKa of E14.
This will develop a deeper understanding of coupling between E14 protonation and TM3 helix
kinking.
Most of our dynamic studies so-far focus on the interconversion, and therefore fall into the ms-s
timescale regime. Studies that extend beyond these timescales are needed to fully link the
dynamics to the function. For example, ps-ns dynamics of different mutants could provide
further information about how slight changes in local flexibility in the TM3 hinge are linked to
the rates of global conformational change. Also further CPMG dynamic studies on the submillisecond dynamics of the C-terminus (Chapter 5) may provide further insight into its role in
transport.
I have aimed to understand the workings of this biological machinery by reconstituting it in vitro.
While necessary for initial characterization, this provides a very simplified environment. In the
case of EmrE, the symmetric bilayer environment in particular is an oversimplification. Adding
another layer of complexity by introducing membrane asymmetry and membrane potential will
be necessary to truly understand how EmrE works.
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In conclusion, our structural and dynamic studies on EmrE not only push boundaries on many
frontiers of NMR, but also demonstrate the usefulness as well as the need to employ the new
paradigm of structure-dynamics-function to understand the mechanisms of inherently dynamic
biological molecules.
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